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Abstract
Pluripotent stem cells provide the opportunity to study human cardiogenesis in vitro, and are a
renewable source of tissue for drug testing and disease models, including replacement
cardiomyocytes that may be a useful treatment for heart failure. Typically, differentiation is
initiated by forming spherical cell aggregates wherein an extraembryonic endoderm (ExE) layer
develops on the surface. Given that interactions between endoderm and mesoderm influence
embryonic cardiogenesis, we examined the impact of human embryonic stem cell (hESC)
aggregate size on endoderm and cardiac development. We first demonstrated aggregate size
control by micropatterning hESC colonies at defined diameters and transferring the colonies to
suspension. The ratio of endoderm (GATA-6) to neural (PAX6) gene and protein expression
increased with decreasing colony size. Subsequently, maximum mesoderm and cardiac
induction occurred in larger aggregates when initiated with endoderm-biased hESCs (high
GATA-6:PAX6), and in smaller aggregates when initiated with neural-biased hESCs (low
GATA-6:PAX6). Additionally, incorporating micropatterned aggregates in a stirred suspension
bioreactor increased cell yields and contracting aggregate frequency. We next interrogated the
relationship between aggregate size and endoderm and cardiac differentiation efficiency in sizecontrolled aggregates, generated using forced aggregation, in defined cardiogenic medium. An
ii

inverse relationship between endoderm cell frequency (FoxA2+ and GATA6+) and aggregate size
was observed, and cardiogenesis was maximized in mid-size aggregates (1000 cells) based on
frequency of cardiac progenitors (~50% KDRlow/C-KITneg) on day 5 and cardiomyocytes (~24%
cTnT+) on day 16. To elucidate a relationship between endoderm frequency and cardiac
differentiation efficiency, aggregates were initiated with varying frequencies of ExE progenitors
(SOX7-overexpressing hESCs). Maximum cardiomyocyte frequencies (~27%) occurred in
aggregates formed with 10 to 25% ExE progenitors. These findings suggest a geometric
relationship between aggregate size and ExE differentiation efficiency subsequently impacts
cardiomyocyte yield, elucidating a mechanism for endogenous control of cell fate through cellcell interactions in the aggregate.
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THE MOTIVATION FOR STUDYING CARDIAC INDUCTION OF HUMAN
PLURIPOTENT STEM CELLS
The excitement surrounding research on human pluripotent stem cells (hPSCs) is largely based
on the expectation that these cells may one day provide a renewable source of human tissue for
cell-based therapies and for testing disease models. Equally as important, however, is the
opportunity these cells present for studying human embryonic development in vitro, which for
ethical reasons would not otherwise be possible in the human system. Insight into stem cell
differentiation to cells belonging to the cardiovascular system is of particular interest because
currently the only effective treatment for heart failure is organ transplantation. The regenerative
capacity of the heart is limited, and heart failure is associated with massive irreversible loss of
cardiomyocytes. Consequently, cell transplantation is emerging as a potential alternative to
organ transplantation (Dimmeler, Zeiher et al. 2005; Laflamme and Murry 2005; Rubart and
Field 2006; Zhu, Hauch et al. 2009). A number of cell types have been under investigation for
their potential to integrate into the heart and improve function following a myocardial infarction
including stem cell-derived cardiomyocytes (Caspi, Huber et al. 2007; Laflamme, Chen et al.
2007; Leor, Gerecht et al. 2007; van Laake, Passier et al. 2007), skeletal myoblasts (Menasche
2003; Menasche 2004), and bone marrow-derived cells (Orlic, Kajstura et al. 2001). The ideal
donor cell type must have the capacity to replace the lost tissue function of the damaged heart
either by integrating and contracting synchronously with host cardiomyocytes or by promoting
the healing of the injured host tissue by paracrine factors (Laflamme, Zbinden et al. 2007).
Given that skeletal myoblasts and bone marrow–derived cells are relatively easy to obtain,
especially autologously, they have been the most extensively investigated in humans but the
results of these clinical trials have been inconclusive (Meyer, Wollert et al. 2006; Abdel-Latif,
Bolli et al. 2007; Menasche 2008) and initial assertions about the cardiomyogenic potential of
these cell types have recently been challenged (Reinecke, Poppa et al. 2002; Balsam, Wagers et
al. 2004; Murry, Soonpaa et al. 2004; Nygren, Jovinge et al. 2004). HPSCs are a promising
candidate cell source because differentiation to cardiomyocytes has been widely demonstrated as
well as differentiation to other non-cardiac cell-types present in the heart (Kehat, KenyaginKarsenti et al. 2001; Xu, Police et al. 2002; Mummery, Ward-van Oostwaard et al. 2003).
Additionally, undifferentiated hPSCs expand indefinitely and hPSC-derived cardiomyoyctes
have a high proliferative capacity (Xu, Police et al. 2002; McDevitt, Laflamme et al. 2005).
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Finally, a number of reports have demonstrated stable integration of hPSC-derived
cardiomyocytes following transplantation into infarcted rodent hearts, resulting in preserved
contractile function (Caspi, Huber et al. 2007; Laflamme, Chen et al. 2007; van Laake, Passier et
al. 2007).
Despite the potential of hPSCs, a number of challenges must still be addressed before cell
transplantation is a viable approach to treating heart failure. While human embryonic stem cell
(hESCs) differentiation has been demonstrated in scalable culture systems (Gerecht-Nir, Cohen
et al. 2004; Cameron, Hu et al. 2006), no reports have been made showing significant cardiac
yields and robust protocols for large scale production of relatively pure hPSC-derived
cardiomyocytes are still in development. A second challenge that remains is poor cell survival
and integration following cell transplantation into the non-vascularized, pro-inflammatory
environment of the infarcted region (Caspi, Huber et al. 2007; Laflamme, Chen et al. 2007; van
Laake, Passier et al. 2007). To resolve this issue a number of approaches are being explored
including the incorporation of pro-survival factors during cell injection (Laflamme, Chen et al.
2007), and tissue engineering strategies such as transplanting biodegradable scaffolds seeded
with cardiomyocytes (McDevitt, Woodhouse et al. 2003), using biocompatible hydrogels as
vehicles for cell delivery (Christman, Vardanian et al. 2004; Martens, Godier et al. 2009), or
producing functional cardiac grafts (Iyer, Radisic et al. 2007; Khademhosseini, Eng et al. 2007;
Radisic, Park et al. 2007).
Efficient hPSC differentiation towards cardiomyocytes at the purity and scale required for
therapeutic applications remains elusive. In attempting to realize the potential for stem cell
based therapy to treat heart failure, research to date has focused on improving cardiac induction
efficiency during hPSC differentiation largely by exploiting what is known about cardiac
development during embryogenesis in other animal systems. However, progress made over the
last 5 years in the development of robust systems for hESC maintenance and cardiac
differentiation has established a framework from which it becomes possible to assay a wide
range of concepts specific to human cardiogenesis.
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PLURIPOTENT STEM CELLS
HESC maintenance
Traditionally, the term pluripotent stem cell referred to embryonic stem cells (ESCs), but in 2006
it was demonstrated that adult cells could also be genetically manipulated to take on a pluripotent
state (Takahashi and Yamanaka 2006). By definition, pluripotent stem cells are able to selfrenew while maintaining the capacity to develop into cells of the three primary germ layers ectoderm, mesoderm, and endoderm – from which all somatic tissues develop. Consequently,
pluripotent stem cells are both a promising donor source for cell therapy, potentially providing
sufficient cell numbers for transplantation into a variety of organs, as well as a useful tool to
study developmental biology.
Human (h)ESCs are derived by isolating cells from the inner cell mass (ICM) of an embryo at
the pre-implantation blastocyst stage and plating the isolated cells onto a feeder layer of cells that
support pluripotency, typically mouse embryonic fibroblast (MEF) feeder cells (Thomson,
Itskovitz-Eldor et al. 1998; Reubinoff, Pera et al. 2000). Human ESCs express the transcription
factor Oct4 and form colonies that are relatively flat and circular with a distinct border
(Reubinoff, Pera et al. 2000). Continuous growth of hESCs requires the presence of a feeder
layer, or coating the dishes with MatrigelTM, an extracellular matrix (ECM) preparation, and
growing the cells in medium that is either feeder-conditioned (Xu, Inokuma et al. 2001), or
supplemented with cytokines including fibroblast growth factor (FGF)-2 and transforming
growth factor (TGF)-β (Amit, Shariki et al. 2004; Wang, Zhang et al. 2005; Wang, Li et al.
2005; Xu, Peck et al. 2005).
Human ESC colonies typically have to be passaged every 4 to 7 days to maintain pluripotency.
One characteristic of hESCs is that they require cell-cell contact and paracrine and autocrine
signaling for survival (Pyle, Lock et al. 2006), and as a result exhibit poor viability upon
dissociation to single cells. Consequently, hESC passaging has routinely been performed by
partial dissociation of hESC colonies using a combination of mechanical and enzymatic
dissociation (Thomson, Itskovitz-Eldor et al. 1998; Amit, Carpenter et al. 2000; Reubinoff, Pera
et al. 2000). This passaging method produces hESC maintenance cultures containing colonies in
a wide range of sizes, and is also a source of variability between passages, as it affects the local
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cellular microenvironment. It has been demonstrated that hESC pluripotency is influenced by
endogenous signaling which takes place within colonies and can be modulated by varying colony
size (Peerani, Rao et al. 2007). In the absence of exogenous cytokines used to maintain
pluripotency, hESCs in regions of high localized cell density (defined as the number of cells per
300 μm radius) retain Oct4 expression. It was shown that maintenance of pluripotency in hESC
colonies is dictated by the interplay of signals secreted by undifferentiated hESCs and their
differentiated progeny, which express markers characteristic of extra-embryonic endoderm
(ExE). Enzyme linked immunosorbent assay (ELISA) analysis of ExE- and hESC-conditioned
medium (CM) revealed that ExE cells secrete bone morphogenetic protein (BMP)-2 at levels six
times higher than hESCs, and that growth differentiation factor-3 (GDF-3), a BMP antagonist, is
secreted by hESCs but was not detected in ExE-CM. ExE secretion of BMP-2 inhibits hESC
self-renewal via Sma mothers against decapentaplegic (Smad1) signaling. In larger colonies,
there is a higher local cell density of hESCs which translates to increased BMP antagonist (GDF3) activity, thereby promoting pluripotency.
Developments have been made to minimize or eliminate this source of variability. In one
approach micro-contact printing is used to pattern ECM onto tissue culture substrates, thereby
specifying hESC colony size and geometry (Peerani, Rao et al. 2007; Lee, Peerani et al. 2009).
In this method, hESCs are enzymatically dissociated to single cells and plated on the ECMmicropatterned surface at extremely high cell densities so that cells reaggregate and adhere to the
ECM islands at a high density. Another method employing microscale technology involves
patterning surfaces with microwells in which hESCs can be maintained as 3-dimensional (3-D)
aggregates (Khademhosseini, Ferreira et al. 2006). The aggregates grow to a maximum size,
defined by the dimensions of the microwells. However, these systems have been strictly used to
demonstrate the capability to control colony size and to examine the effects of controlling colony
size, and for technical reasons have not been used for long term maintenance of hESC cultures.
Some of the more recently derived cell lines, such as the CA1, CA2, and HES2 cell lines, have
been adapted for single cell enzymatic dissociation and therefore, in these lines, passage to
passage variability arising from partial colony dissociation has been reduced.
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Differentiation of hESCs
In vitro ESC differentiation is routinely carried out by forming embryoid bodies (EBs) which are
three dimensional aggregates of hESCs in suspension. Aspects of embryonic development are
recapitulated within the EB, wherein cells of the three embryonic germ layers - endoderm,
ectoderm and mesoderm - develop (Doetschman, Eistetter et al. 1985; Itskovitz-Eldor,
Schuldiner et al. 2000; Xu, Inokuma et al. 2001) and subsequently differentiate into committed
cell types including neurons, glia, skeletal and cardiac muscle cells, hematopoietic cells, hepatic
cells and insulin-secreting (pancreatic) cells (Itskovitz-Eldor, Schuldiner et al. 2000; Xu,
Inokuma et al. 2001).
Controlling aggregate size has been one of the major challenges in EB-mediated hESC
differentiation. As previously discussed single cell dissociation of hESCs is avoided and
therefore human EBs have typically been initiated by partial enzymatic digestion of hESC
colonies, similar to the technique used to passage hESC colonies (Kehat, Kenyagin-Karsenti et
al. 2001; Xu, Police et al. 2002). This method of EB formation leads to variability in EB size
within cultures as well as average EB size between cultures (Itskovitz-Eldor, Schuldiner et al.
2000; Weitzer 2006) and consequently makes it difficult to achieve reproducible, consistent, and
efficient hESC differentiation. Attempts to control human EB size have involved either forced
aggregation of defined cell numbers (Ng, Davis et al. 2005; Burridge, Anderson et al. 2007;
Ungrin, Joshi et al. 2008) or the use of microwells to form 3-D hESC aggregates of specified
dimensions which can then be transferred to suspension to form mono-disperse EBs
(Khademhosseini, Ferreira et al. 2006; Mohr, de Pablo et al. 2006; Mohr, Zhang et al. 2009).
In the first published report on EBs formed by forced aggregation of defined numbers of hESCs,
it was observed that EB size influenced hematopoietic differentiation, with a minimum of 500
cells required for efficient blood formation and 1000 cells for optimum erythropoiesis (Ng, Davis
et al. 2005). Building on this EB formation strategy, subsequent studies examined the effect of
input hESC status and medium components on the efficiency of forced cell aggregation EB
formation (Ungrin, Joshi et al. 2008). It was observed that aggregate formation efficiency was
inefficient when initiated with hESC input populations highly expressing Oct4 protein, a marker
of pluripotency. Incorporating a “pre-differentiation” step, in which maintenance medium is
removed from hESC colonies and replaced with serum-containing medium 72 hours prior to EB
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formation, led to a significant improvement in aggregation efficiency approaching 100%. This
observation highlighted a separate issue that affects all differentiations studies. Variable input
populations, with respect to expression levels of pluripotency markers as well as differentiationassociated markers, are a result of variability of hESC colony size, which is in large part a result
of passaging hESC colonies as cell clumps (Peerani, Rao et al. 2007). It was observed that the
“pre-differentiation” step could be eliminated and efficient aggregation of hESCs could still be
achieved in the presence of p160-Rho associated coiled-coil kinase (ROCK) inhibitor Y-27632.
EBs formed via forced aggregation are not only size-specified but also display consistent shape,
allowing for the reproducible observation of tissue specific spatial organization within the EB.
EBs formed by forced aggregation develop two distinct regions, an inner core that expresses
Oct4, and a disordered outer layer that expresses a number of markers associated with primitive
endoderm (Ungrin, Joshi et al. 2008).
An alternate means to control EB size uses microwell patterned surfaces. This method involves
passaging hESC colonies as small clumps into size-specified microwells that have been either
coated with Matrigel (Mohr, de Pablo et al. 2006; Mohr, Zhang et al. 2009) or MEFs
(Khademhosseini, Ferreira et al. 2006) and maintaining undifferentiated hESCs as 3-D colonies.
The colonies reach a maximum size defined by the volume of the microwell used, and can then
be transferred to suspension in differentiation medium to develop as size-specified EBs. EBs
cultured in this system have been proven to contain cells expressing proteins associated with
each of the embryonic germ layers (Mohr, de Pablo et al. 2006), and have also been used to
examine the effect of EB size on cardiac lineage induction from hESCs (Mohr, Zhang et al.
2009).
EARLY EVENTS IN EB DEVELOPMENT PARALLEL GASTRULATION DURING
EMBRYOGENESIS
In the eight-cell morula-stage embryo, a process called compaction - in which inner blastomeres
form a tight ball - produces the ICM (Figure 1.1A). Meanwhile blastomeres located on the
exterior of the morula flatten and form the trophoblast. Following compaction, a fluid-filled
cavity called the blastocoele develops inside the embryo (blastocyst stage), and ICM in contact
with the blastocoele differentiates to primitive endoderm (PE) which then either differentiates to
visceral endoderm where it is in contact with the ICM or parietal endoderm where it is in contact
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with the trophoblast. At this stage, the remaining cells within the ICM begin to differentiate into
an epithelial layer that is referred to as the epiblast or primitive ectoderm (Johnson and Ziomek
1981; O'Shea 2004). Development of the three primary germ layers occurs in the epiblast by a
process called gastrulation (Figure 1.1B). Gastrulation is initiated in the posterior epiblast by
movement of cells through the primitive streak (PS) where cells undergo an epithelial to
mesenchymal transition, exiting the PS as mesoderm in the proximal-anterior region of the
epiblast and as definitive endoderm in the distal-anterior region (Gadue, Huber et al. 2005; Rust,
Sadasivam et al. 2006; Murry and Keller 2008).
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Adapted from O’Shea. Biol Reprod. 2004
Dec;71(6):1755-65.
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Murry & Keller. Cell. 2008 Feb
22;132(4):661-80

Figure 1.1: Development of the early mouse embryo. (A) In the morula, the inner (blue) cells will form ICM
and the outer (pink) cells will form trophoblast. In the early blastocyst, a cavity (the blastocoele, B) forms between
the inner cell mass and the trophoblast; the embryo is still enclosed in the zona pellucida (ZP). By the late
blastocyst stage, the ICM cells in contact with the blastocoele differentiate into the primitive endoderm (PE), which
later forms visceral endoderm on the epiblast side and parietal endoderm on the trophoblast side. At implantation the
proamniotic cavity begins to form within the ICM. Cells of the ICM differentiate into an epithelial layer, the
epiblast, (E). (B) Gastrulation in the mouse embryo. Shown are the posterior region of the primitive streak that
expresses the marker Brachyury (blue), and the anterior region of the primitive streak that coexpresses both
Brachyury and Foxa2 (red). At the top of the embryo, epiblast cells are shown entering the primitive streak (thick
black arrows). The yellow/orange region depicts newly formed mesoderm, and migration of these cells from the
primitive streak is indicated by thin black arrows. Also depicted is the movement of the earliest definitive endoderm
cells (red arrow at bottom).
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EBs are thought to mimic the environment of the peri-implantation embryo where interactions
between various cell types facilitate inductive events. Similar to the embryo where an epithelial
layer of PE forms and contacts the epiblast, one of the earliest events during EB development is
the organization of the cells into an epithelial layer of PE surrounding an inner core of epiblastlike pluripotent cells (Coucouvanis and Martin 1995; Abe, Niwa et al. 1996; Coucouvanis and
Martin 1999), followed by the expression of gene and protein markers that are associated with
the PS such as Brachyury (Kispert and Herrmann 1994) and Mixl1 (Hart, Hartley et al. 2002).
Many proteins involved in commitment to the endoderm and mesoderm lineage in the PS, such
as TGF-β, Nodal and Wingless Int (Wnt) (Conlon, Lyons et al. 1994; Hogan 1996; Yamaguchi
2001), are the same and it is different levels of activation and inhibition of pathways associated
with these proteins that regulate germ layer induction (Gadue, Huber et al. 2005). In terms of
timing, the expression of genes associated with the PS and germ layer commitment in the EB
recapitulates gastrulation in the embryo (St-Jacques and McMahon 1996; Dvash and Benvenisty
2004; Keller 2005; Murry and Keller 2008). However, while gastrulation occurs in a precise,
spatially organized manner during embryogenesis, differentiation of PS-like cells in the EB is
spatially chaotic. It is believed that in the embryo distinct signaling environments exist that are
defined by location in relation to extraembryonic and embryonic tissues which secrete signals
that direct lineage commitment (Rust, Sadasivam et al. 2006; Murry and Keller 2008). However,
in contrast to the epiblast, EBs lack polarity and as a result spatially disorganized germ layer
induction may be due to the lack of position-specific cues.
PARALLELS BETWEEN CARDIOGENESIS IN THE EMBRYO AND IN THE EB
During embryogenesis, the heart is the first organ to fully form after gastrulation (Menard, Grey
et al. 2004), when oxygen delivery by diffusion is no longer sufficient in the growing embryo.
Forming the anatomical structure of the heart involves the precise spatiotemporal coordination of
signals from neighboring tissues that promote or inhibit cardiac specification, proliferation and
migration of uncommitted precardiac mesoderm. Inductive cues originate from the anterior
primitive endoderm (Sugi and Lough 1994; Schultheiss, Xydas et al. 1995; Schultheiss, Burch et
al. 1997; Schultheiss and Lassar 1997) and lateral regions of the embryo (Schultheiss, Xydas et
al. 1995; Schultheiss, Burch et al. 1997; Schultheiss and Lassar 1997), while cardiogenesis is
suppressed in the adjacent mesoderm by factors secreted by the neuronal tube (Climent, Sarasa et
al. 1995; Schultheiss, Burch et al. 1997; Raffin, Leong et al. 2000). Members of the TGF-β
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superfamily (TGF-β, nodal, activin and BMP) and the FGF family are known cardiogenic
morphogens that activate cardiac transcription factors (Menard, Grey et al. 2004). Wnt-related
signals and members of the Wnt family are also important for cardiac induction (Sachinidis,
Fleischmann et al. 2003), by playing both a repressive role, via the canonical Wnt/β-catenin
pathway, and an inductive role via the non-canonical Wnt/Ca2+ and c-Jun N-terminal kinase
pathways (Povelones and Nusse 2002).
Inductive signals from the anteriolateral(embryogenesis)/primitive(EB) endoderm
During embryonic development, precardiac mesoderm is in close contact with endoderm. A
number of studies across various species have demonstrated that interactions between endoderm
and overlying mesoderm are involved in cardiac differentiation (Orts Llorca 1963; Jacobson and
Duncan 1968; Sugi and Lough 1994; Nascone and Mercola 1995; Schultheiss, Xydas et al. 1995)
and, more specifically, play an inductive role as evidenced by the generation of beating cardiac
tissue in cocultures of non-cardiogenic embryonic tissue explants and endodermal tissue
(Schultheiss, Xydas et al. 1995). The inductive characteristic of the endoderm can be attributed
to TGF-β superfamily and FGF family growth factors, expressed by anterior lateral endoderm,
that have been reported to be involved in cardiac differentiation.
The TGF-β superfamily, involved in a wide range of developmental processes, includes TGF-βs,
activins, nodals and BMPs. Binding of TGF-β family proteins to their receptors leads to
activation of intracellular mediators of the Smad family. Smad2 and Smad3 transduce signals
for TGF-β-like ligands, such as TGF-β, activin and nodal while Smad1, 5 and 8 transduce
signals for BMP-like ligands (Lagna, Hata et al. 1996; Candia, Watabe et al. 1997; Shi, Hata et
al. 1997). Upon phosphorylation, these receptor-regulated (R)-Smads form complexes with
Smad4, which are subsequently translocated to the nucleus to regulate activation of transcription
factors, such as cardiac transcription factors Nkx-2.5, GATA-4, and Tbx factors (Massague and
Chen 2000; Schlange, Andree et al. 2000; Moustakas, Souchelnytskyi et al. 2001; Attisano and
Wrana 2002; Harvey 2002; Wakefield and Roberts 2002; Attisano and Labbe 2004; Menard,
Grey et al. 2004). FGF family proteins (FGF-2 and FGF-4) have been shown to support
cardiomyocyte induction during embryonic development mainly by stimulating proliferation of
mesodermal cells in vitro (Mima, Ueno et al. 1995; Lough, Barron et al. 1996; Schultheiss and
Lassar 1997; Ladd, Yatskievych et al. 1998; Barron, Gao et al. 2000; Kawai, Takahashi et al.
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2004). During embryogenesis, these growth factors, originating from the anterior and lateral
endoderm, synergize in a precise spatial and temporal program to support and induce
cardiogenesis in neighboring precardiac mesoderm (Figure 1.2).
Studies performed using avian embryo explants demonstrated the coordinated timing of signals
from the endoderm that direct heart formation during embryogenesis (Ladd, Yatskievych et al.
1998). TGF-β1 and activin appear to have a similar effect in inducing cardiomyocyte
differentiation in posterior epiblast tissue (including regions not fated to form heart)
(Yatskievych, Ladd et al. 1997; Ladd, Yatskievych et al. 1998), but not in non-cardiogenic
mesoderm (Schultheiss, Burch et al. 1997; Ladd, Yatskievych et al. 1998). Conversely, BMP-2
and -4, in combination with FGF-4, induce cardiac differentiation of non-cardiogenic mesoderm
(Lough, Barron et al. 1996; Schultheiss and Lassar 1997; Ladd, Yatskievych et al. 1998; Barron,
Gao et al. 2000), but fail to support cardiogenesis in posterior epiblast. FGF-2 is expressed in
both endoderm as well as myocardial cells of the developing embryo (Parlow, Bolender et al.
1991; Sugi, Sasse et al. 1993). Studies indicate that FGF is necessary for proliferation of
precardiac mesoderm given that hybridization of FGF-2 mRNA to a complementary
oligodeoxynucleotide, on day 4 of explant cultures, results in a dramatic reduction of
proliferating myocardial cells, but not when exogenous FGF-2 was added with the
oligodeoxynucleotide (Mima, Ueno et al. 1995). From these findings, it appears that directing
pre-gastrula epiblast to terminally differentiated cardiomyocytes consists of TGF-β or activin
signaling during early embryonic development to specify the mesendoderm lineage, followed by
BMP signaling to induce terminal cardiomyocyte differentiation in precardiac mesoderm, which
is supported by FGF’s role in precardiac mesoderm proliferation.
Observations on the cardiogenic effects of these growth factors in the embryo have been
reinforced in the ESC differentiation system. EB cultures initiated with ESCs that have been
primed with BMP-2 or TGF-β for 24 hours express higher levels of mRNA for brachyury
(mesodermal marker) and cardiac transcription factors Nkx-2.5 and myocyte enhancer factor 2C
(Mef2c), and exhibit larger beating areas and increased α-actinin staining (Behfar, Zingman et
al. 2002). It has also been shown that a combination of FGF-2 and BMP-2 can efficiently
enhance cardiac induction of ESC differentiation cultures (Kawai, Takahashi et al. 2004).
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Similar to cardiogenesis in the developing embryo, it is expected that the order and timing of
signals is critical during ESC differentiation to cardiomyocytes.
Nodal, a TGF-β protein that signals by binding activin receptors via membrane-bound Cripto
protein (Reissmann, Jornvall et al. 2001; Yeo and Whitman 2001), appears to play a role in
cardiac specification during early differentiation. Timing of Nodal signaling is important, as
endogenous expression of its cofactor Cripto is detected at the earliest stages of ESC
differentiation and is no longer present at stages where EB contractions are observed (Parisi,
D'Andrea et al. 2003). In kinetic studies using Cripto-/- ESCs it was demonstrated that addition
of recombinant Cripto during the first 2 days of culture restored the differentiation ability of
Cripto-/- ESCs, whereas addition at later time-points led to dramatically reduced cardiomyocyte
differentiation (Xu, Liguori et al. 1998; Parisi, D'Andrea et al. 2003). Impaired cardiac induction
and differentiation of ESCs upon addition of Nodal antagonist demonstrates that Cripto signaling
is Nodal-dependent. It should be noted that specification of the cardiac fate seems to occur at the
expense of the neural fate, given that addition of Cripto protein to Cripto-/- ESCs during the first
2 days restores cardiomyocyte differentiation and results in a dramatic inhibition of neural
differentiation, while Cripto addition from day 3 and on results in progressive impairment of
cardiac differentiation and increases differentiation to a neural phenotype (Parisi, D'Andrea et al.
2003).
BMP signaling impacts cardiac differentiation in EBs in a temporal manner. In a time course
study investigating different time windows of noggin (a BMP inhibitor) exposure on incidence of
EB beating, it was observed that depending on the developmental stage of the differentiation
culture BMP signaling can have both a positive and negative effect on the efficiency of cardiac
induction (Yuasa, Itabashi et al. 2005). Inhibiting BMP from 3 days prior to EB formation until
day 3 of differentiation yielded a 95% incidence of beating EBs, whereas initiating BMP
inhibition upon EB formation or later reduced beating incidence to less than 40%. This
observation is consistent with what has been determined in posterior epiblast and precardiac
mesoderm explants, where it has been established that BMP signaling is required for terminal
cardiomyocyte differentiation but appears to inhibit mesoderm specification during early
differentiation.
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An assessment of the data indicates that precardiac cells interpret BMP signals in a cell-type
specific manner. As has been outlined previously, TGF-β/activin/Nodal proteins signal via
different Smad mediators than BMP proteins. BMP inhibition of TGF-β/activin/Nodal activity
during early cardiac differentiation may be due to competition for Smad4 by Smad2/3 (BMP
downstream transducers) and Smad1/5/8 (TGF-β, activin and Nodal downstream transducers).
Smad4 has been shown to be essential during cardiogenesis. In mouse embryos, disruption of
Smad4 specifically in the myocardium leads to reduced proliferation and increased apoptosis of
cardiomyocytes, heart defects and eventually embryonic lethality (Qi, Yang et al. 2007; Song,
Yan et al. 2007). Therefore cells at different stages of differentiation may be exhibiting different
responses to BMP signaling as a result of Smad4 sequestering by the TGF-β/activin/Nodal
pathways.
TGF-β
Activin
Nodal
Wnt

ESC/
epiblast
Oct4+

mesendoderm
Bry+
Mixl1+

TGF-β
Activin
Nodal

precardiac
mesoderm

FGF-2/4
BMP4

Flk1/KDR+
Wnt

cardiomyocytes
Nkx2.5+
Gata4+
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cTnT/cTnC+
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Figure 1.2: Signals known to be involved in directing cardiogenesis and the markers expressed at each stage
of development.

Inductive/Inhibitory signals from the neuronal tube
Wnt signaling proteins play both a repressive and supportive role in heart morphogenesis.
Canonical Wnt signaling suppresses cardiac differentiation by degradation of β-catenin. Wnts’
repressive activity is inhibited by antagonists Crescent and dickkopf homolog 1 (DKK1)
(expressed in anterior endoderm during gastrulation), which subsequently results in the induction
of beating muscle. Inhibition of Wnt signaling promotes heart formation in the anterior lateral
mesoderm, whereas active Wnt signaling in the posterior lateral mesoderm promotes blood
development (Marvin, Di Rocco et al. 2001). In the non-canonical pathway Wnt11 prevents
signaling of other Wnts, amplifying the cardiogenic signal (Menard, Grey et al. 2004). This
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pathway promotes heart induction by upregulating Nkx-2.5 and GATA-4 in xenopus embryos
and the P19 pluripotent cell line (Pandur, Lasche et al. 2002). It has been shown, through lossand gain-of-function experiments that Wnt11 is required for heart formation in xenopus embryos
and is sufficient to induce a contractile phenotype in embryonic explants. Treating P19 cells
with murine Wnt-11 conditioned medium triggers cardiogenesis, which indicates that the
function of Wnt-11 in heart development has been conserved in higher vertebrates (Pandur,
Lasche et al. 2002). In mESCs, a positive correlation has been observed between Wnt and Nkx2.5 expression. Furthermore, in the same mouse (m)ESC study, treatment of EBs with medium
containing Wnt11 increased expression of Nkx2.5 in a dose-dependent manner.
Transcription factors: GATA proteins, Nkx-2.5, Smads, T-box proteins
Activation of cardiac gene promoters cannot be carried out by one transcription factor alone, but
results from the coordinated activity of multiple transcription factors. Cardiac transcription
factors include, among others, Nkx-2.5, GATA-4, 5, 6, Tbx5 and Tbx20, and several Smad
proteins (Menard, Grey et al. 2004).
The activity of GATA proteins is modulated by their interactions with other transcriptional
coactivators and repressors. GATA-4 promotes cardiac muscle development and regulates
expression of several cardiac specific genes including myosin heavy chain (MHC), cardiac
troponin T and cardiac troponin C (cTnT/C), and Atrial Natriuretic Protein (ANP) (Svensson,
Tufts et al. 1999). Nkx-2.5 is an important coactivator of GATA-4 in initiating transcription of
cardiac specific genes. T-box gene family transcription factors appear to contribute to several
aspects of cardiac development including cardiac lineage determination, chamber specification
and specialization of the conduction system. T-box genes act in conjunction with other families
of transcription factors (Nkx and GATA) to regulate cardiac gene expression (Bruneau, Nemer et
al. 2001; Hiroi, Kudoh et al. 2001; Takeuchi and Bruneau 2009).
Smad proteins mediate BMP signaling. BMPs phosphorylate cytoplasmic R-Smads1, 5, or 8
which interact with Smad4. This Smad complex is then translocated to the nucleus where it
associates with other transcription factors to activate BMP-responsive genes (Attisano and
Wrana 2000). Precardiac cells interpret the BMP signals in a cell-type specific manner. A
possible molecular basis linking cardiac gene regulation and the BMP signaling pathway has
been proposed from experiments that link Smad4 activation of Nkx-2.5 transcription with
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GATA-4 acting as a cofactor. Mesodermal cells recognize and interpret the BMP-cardiacpromoting signal because the activating region of the mouse Nkx-2.5 gene contains binding sites
for Smad adjacent to two essential GATA sites (Lien, McAnally et al. 2002).
HUMAN EMBRYONIC STEM CELL DIFFERENTIATION TO CARDIOMYOCYTES.
Cardiac induction in serum-containing medium
The first published study demonstrating cardiomyocyte differentiation from hESCs employed
EB-based induction (Kehat, Kenyagin-Karsenti et al. 2001). EBs were formed by dissociating
hESC colonies into clumps containing 3 to 20 cells and culturing these clumps in suspension in
serum-containing medium. After 7 to 10 days in suspension, EBs were plated onto culture
dishes and spontaneously contracting areas were observed in 8.1% of the EBs after 20 days.
Electron microscopy and electrophysiologic recordings displayed characteristic cardiomyocyte
morphology and action potentials, respectively. Cells dissected from these contracting areas
stained positive for several cardiac specific antibodies including α-myosin heavy chain (MHC),
α-actinin, desmin, troponin I and ANP. In a subsequent report on EB-based hESC
differentiation to cardiomyocytes, beating was observed in 70% of EBs (Xu, Police et al. 2002).
It was suggested that the increased efficiency could have been due to differences in culture
conditions during hESC maintenance, in methods of EB formation, and in the quality of serum
used for differentiation. In the same study, using Percoll density centrifugation the population
was enriched to a concentration of approximately 70% cardiomyocytes (Xu, Police et al. 2002).
A third study reported 10 to 25% of EBs were spontaneously contracting after EB-based hESC
differentiation (He, Ma et al. 2003). A number of potential sources of variability may account
for the different cardiac induction efficiencies achieved between different researchers. Using the
number of contracting EBs as a measure of cardiac induction efficiency is one possible source of
variability given that detection of beating may vary between individuals and that frequency of
beating EBs does not accurately reflect the efficiency of cardiomyocytes generated per input
hESC. Another source of variability is that in each of these studies the method of EB formation
from hESCs was carried out by enzymatic dissociation of hESC colonies into cell clumps. It is
likely that the average EB size, as well as variability of EB sizes fluctuated significantly between
labs. Additionally these EBs were cultured in the presence of fetal bovine serum (FBS), a
mixture of undefined components known to exhibit lot-to-lot variability.
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Cardiac induction in endoderm co-cultures
An alternate approach to EB based differentiation has been to induce cardiac induction of hESC
colonies by coculturing them with endoderm cells, perhaps mimicking the observation in the
embryo where endodermal tissues appear to promote and/or support mesoderm and cardiac
induction during embryogenesis. Cardiogenesis was observed in hESC aggregates cultured on a
visceral endoderm feeder layer (END-2 cell line), as evidenced by the appearance of beating
areas in 35% of aggregates, and the emergence of cells expressing α-actinin, tropomyosin, and
ryadonine receptors (Mummery, Ward-van Oostwaard et al. 2003; Passier, Oostwaard et al.
2005). In EBs cultured in END-2-conditioned, serum-free medium (Xu, Graichen et al. 2008),
beating was observed in 60 to 70% of EBs after 12 days of differentiation. The positive effect
that END-2-conditioned medium (END2-CM) exerted on cardiac induction of hESCs was
associated with an absence of insulin in the serum free medium. An ELISA analysis on END2CM revealed a significant drop in insulin concentration to negligible levels after 3 to 4 days of
exposure to END-2 cells, and beating activity and the expression of cardiac genes decreased with
increasing concentrations of exogenously added insulin to END2-CM. A subsequent report
examining the mechanism by which insulin leads to reduced cardiogenesis during hESC
differentiation found that the presence of insulin did not prevent differentiation of any specific
lineage but favored neurectoderm differentiation at the expense of the mesendodermal lineages
(Freund, Ward-van Oostwaard et al. 2008).
Cardiac induction in serum-free, defined conditions
Recently it has been demonstrated that it is possible to efficiently generate hESC-derived
cardiomyocytes in the absence of serum or mouse cell conditioned medium and without coculturing hESCs with animal-derived inductive cell types (Yang, Soonpaa et al. 2008). The
protocol, based on signaling that occurs during embryonic heart formation, consists of adding
combinations of growth factors to the EBs in stages temporally associated with the appropriate
period of development. The first stage (EB days 1 to 4) is associated with the induction of a PSlike cell population. Activin A and BMP4, growth factors which have been shown to upregulate
PS markers brachyury and Wnt3A (Kispert and Herrmann 1994; Liu, Wakamiya et al. 1999), are
added to the EBs. In the next stage (EB days 4 to 8), the cardiac mesoderm commitment stage,
DKK1 and vascular endothelial growth factor (VEGF) are added. VEGF promotes expansion
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and maturation of mesoderm cells (population expressing kinase insert domain protein receptor,
KDR, known as fetal liver kinase-1, FLK1, in the mouse system), while DKK1 inhibits Wnt
activity. Although Wnt signaling is required at the onset of differentiation for PS induction
(Lindsley, Gill et al. 2006; Naito, Shiojima et al. 2006; Ueno, Weidinger et al. 2007) at this stage
endogenous Wnt signaling promotes induction of the definitive endoderm at the expense of
cardiac mesoderm (Gadue, Huber et al. 2006). In the final stage (starting on EB day 12), the
cardiac cell expansion stage, DKK1 and VEGF continue to be present in the medium and FGF-2
is added to support expansion of the cardiac population. Human ESCs differentiated under these
conditions yielded a population of cardiac progenitors on EB day 6, identified by expression of
KDR at low levels and absence of CKIT expression, and ultimately yielded a population with
30% of cells expressing cTnT by EB day 14. Plating EBs on day 4 routinely resulted in
contracting sheets of cardiomyocytes after 7 to 10 days.
A 2-D system for directed cardiac differentiation of hESCs has also been developed (Laflamme,
Chen et al. 2007). In this technique, first hESC colonies are seeded onto MatrigelTM-coated
plates and cultured in the presence of MEF-CM for 6 days to reach confluence. Cardiac
induction is initiated by replacing MEF-CM with serum-free medium containing Activin A for
24 hours, followed by 4 days of treatment with BMP4. Following day 5, the cells are cultured in
the complete absence of cytokines. Twelve days following Activin A treatment, widespread
spontaneous contractions are observed, and typically 30% of cells express the cardiac contractile
protein marker α-actinin. It was demonstrated that by employing Percoll gradient centrifugation
cardiomyocytes could be enriched in these cultures to a frequency of 82.6 ± 6.6%.
SCALABLE PRODUCTION OF HPSC-DERIVED CARDIOMYOCYTES
While hPSCs provide a unique opportunity to study human embryonic development that would
not otherwise be possible in vivo, these cells are also an exciting source of renewable tissue for
novel clinical applications and cell transplantation strategies to treat disease. The ability to
generate large numbers of HPS cell-derived differentiated cells is critical to developing these
strategies. Stirred suspension cultures are a popular approach to scale-up static dish-based cell
cultures because they improve culture homogeneity, permit online monitoring and control of pH
and dissolved oxygen concentration, and continuous medium perfusion can be easily enabled
(Collins, Miller et al. 1998; Madlambayan, Rogers et al. 2001; Cabrita, Ferreira et al. 2003;
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Kwon, Kim et al. 2003; Zandstra, Bauwens et al. 2003; Dang, Gerecht-Nir et al. 2004; Bauwens,
Yin et al. 2005).
Scalable stirred suspension bioprocesses for the generation of mESC-derived cardiomyocytes
have been well developed (Zandstra, Bauwens et al. 2003; Bauwens, Yin et al. 2005; Schroeder,
Niebruegge et al. 2005). The first major challenge to implementing stirred suspension
bioreactors for EB-based differentiation was that EBs tend to agglomerate during the first 4 days
of differentiation due to the expression of surface markers on ESCs that promote cell-cell
aggregation (Dang, Kyba et al. 2002). Initial attempts to prevent EB agglomeration focused on
hydrogel encapsulation (Magyar, Nemir et al. 2001; Dang, Gerecht-Nir et al. 2004; Bauwens,
Yin et al. 2005; Dang and Zandstra 2005) of ESC aggregates to provide a barrier between EBs.
It was subsequently demonstrated that aggregate formation could be controlled by optimizing
stirring conditions, specifically examining impeller type and stirring speed (Schroeder,
Niebruegge et al. 2005; Niebruegge, Nehring et al. 2008). To purify the heterogeneous
differentiating cultures for cardiomyocytes and to deplete undifferentiated cells, a genetic
selection technique was used (Klug, Soonpaa et al. 1996; Li, Pevny et al. 1998; Marchetti,
Gimond et al. 2002; Zandstra, Bauwens et al. 2003), whereby ESCs were genetically engineered
to be neomycin resistant upon expression of myosin heavy chain (MHC). This technique has
been demonstrated to efficiently enrich mESC-derived cardiomyoyctes to greater than 70% in
the stirred suspension system (Zandstra, Bauwens et al. 2003). Improved culture homogeneity
has not only been achieved via stirring, but also by incorporating a settling tube to separate EBs
from the culture medium which permitted continuous medium perfusion thereby preventing wide
variations in medium component concentrations including glucose and lactate (Bauwens, Yin et
al. 2005; Niebruegge, Nehring et al. 2008). Additionally, by implementing direct control of
dissolved oxygen concentration in a bioreactor system, improved cardiomyocyte yields per input
ESC have been observed under hypoxic conditions (Bauwens, Yin et al. 2005).
The central challenge in generating large numbers of hESC-derived differentiated cell types has
been the poor proliferation that has been observed during hESC differentiation. In contrast to
what has been observed during mESC differentiation, during EB-based hESC differentiation in
static culture cell expansion is typically not observed (Gerecht-Nir, Cohen et al. 2004; Cameron,
Hu et al. 2006). Stirred suspension culture of human EBs has generally consisted of an initial 24
hour static EB formation step to prevent hESC aggregates from breaking apart under dynamic
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conditions (Cameron, Hu et al. 2006). Interestingly, when human EBs are cultured in dynamic
systems, such as stirred suspension bioreactors, proliferation does occur, however cell-fold
expansion is still far lower (less than 20-fold) (Gerecht-Nir, Cohen et al. 2004; Cameron, Hu et
al. 2006) than what has been observed during mESC differentiation (greater than 60-fold)
(Zandstra, Bauwens et al. 2003; Dang, Gerecht-Nir et al. 2004; Bauwens, Yin et al. 2005).
While the improved cell expansions may be attributed to the obvious benefits of stirred
suspension such as medium homogeneity and reduced variations in metabolic byproducts, the
observation that under dynamic conditions human EB concentrations are maintained, while
under static conditions EB concentrations sharply decrease in the first 4 days of culture indicate
that cell expansion is largely due to the prevention of EB agglomeration in stirred suspension
(Cameron, Hu et al. 2006). Further confirmation of reduced EB agglomeration under dynamic
conditions is the visual observation that EBs grown in spinner flasks are more homogenous in
size and shape than those cultured statically (Cameron, Hu et al. 2006). Importantly, it was
demonstrated that representative tissues from the three germ layers are produced in human EBs
cultured in stirred suspension (Cameron, Hu et al. 2006) and that differentiation efficiency to the
hematopoietic (Cameron, Hu et al. 2006) and cardiac lineages (Niebruegge, Bauwens et al. 2009)
are at least comparable to what is achieved under static conditions.
Other dynamic cell culture systems have also been explored for hESC differentiation (GerechtNir, Cohen et al. 2004). Massive cell death and EB agglomeration was observed in human EBs
cultured in high aspect rotating vessels. EB agglomeration was prevented in slow turning lateral
vessels, and differentiation to cells representing the three germ layers was observed. These
observations suggest that while mixing is crucial for cell expansion during human EB
differentiation, it is also essential to ensure that stirring is mild enough to prevent EB
agglomeration and cell death.
Oxygen concentration has been shown to influence mouse pluripotent stem cell differentiation
towards the hematopoietic and cardiac lineages (Gassmann, Fandrey et al. 1996; Sauer, Rahimi
et al. 2000; Dang, Gerecht-Nir et al. 2004; Bauwens, Yin et al. 2005). Under hypoxic conditions
cardiac induction is enhanced, paralleling embryogenesis, wherein the development of the
cardiovascular system takes place as diffusion of oxygen becomes limited by the growth of the
embryo (Ramirez-Bergeron and Simon 2001). It is believed that the mechanism for the effect
that hypoxia exerts on cardiomyocyte differentiation involves the activation of hypoxia inducible

20

factor 1 (HIF-1) which activates a number of growth factors that are associated with
cardiogenesis including VEGF and FGF-2 (Gassmann, Fandrey et al. 1996; Ramirez-Bergeron
and Simon 2001; Dang, Gerecht-Nir et al. 2004).
Improving the yield of specific differentiated cell populations can be achieved by applying the
developments that have been made to define cytokine and growth factor conditions that promote
commitment of specific cell lineages from hESCs, optimizing hESC aggregate size, improving
feeding strategies, controlling oxygen concentration, and incorporating specific cell line
enrichment strategies such as antibiotic selection in a scalable dynamic culture system.
THE CELL AGGREGATE AS A SYSTEM TO EXAMINE THE EFFECT OF
ENDOGENOUS SIGNALING ON CARDIAC INDUCTION
Differentiation can be skewed in hPSC aggregates to favor cardiac induction
As a differentiation system, the EB has often been viewed as a simple technique to demonstrate
the capacity of pluripotent stem cells to differentiate to a number of different cell types, but a
poor technique as far as controlling differentiation of stem cells to one specific cell fate. A
defining characteristic of the EB is that it gives rise to a heterogeneous population representing
all the somatic tissue types. However, given that during embryogenesis spatial and temporal
cues from neighboring tissues guide development, it is likely that the heterogeneity within the
EB produces an environment with the necessary complexity of signals, regulated by the timing
and proportion of emerging inductive tissue-associated cells, to produce all the cell types in the
developing embryo. For this reason, the aggregate-based differentiation system is a valuable tool
for studying the effect of endogenous signaling on induction efficiency of specific cell fates
during pluripotent stem cell differentiation.
The term embryoid body, or EB, is widely used to refer to uncontrolled differentiation induced
by culturing aggregates of pluripotent stem cells in suspension, and should be clearly
distinguished from aggregate-based differentiation cultures wherein culture parameters are
strictly controlled to promote differentiation of a specific cell type. Although the EB cannot give
rise to a pure population of any specific cell fate, it is known that the proportions of cells
belonging to the mesoderm lineage can be modulated in hPSC aggregates by manipulating the
culture system in a variety of ways including addition of exogenous factors (Yang, Soonpaa et al.
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2008) and controlling oxygen concentration (Bauwens, Yin et al. 2005) as previously discussed,
as well as by genetically modifying input stem cells (Holtzinger, Rosenfeld et al. 2010), and
optimizing aggregate size (Burridge, Anderson et al. 2007; Mohr, Zhang et al. 2009).
Aggregate size influences cardiac induction efficiency
As has been previously discussed, a variety of methods have been developed to control hESC
aggregate size and this parameter has been shown to influence cardiac induction efficiency
(Burridge, Anderson et al. 2007; Mohr, Zhang et al. 2009). In one study using forced
aggregation to form hESC aggregates starting with 1000, 3000 and 10000 cells per aggregate, the
frequency of spontaneously contracting aggregates was analyzed with respect to input cell
number (Burridge, Anderson et al. 2007). It was observed that the frequency of beating
outgrowths arising from size-controlled aggregates of all sizes (approximately 10-25%) was
always higher than the frequency of beating outgrowths arising from non-size controlled EBs
formed in mass culture (approximately 2%). The highest frequency of beating aggregates and
highest levels of cardiac gene expression occurred in cultures initiated with the highest aggregate
size (10000 cells/aggregate). Another report demonstrated differentiating hESC aggregate size
control by maintaining undifferentiated hESC colonies in microwells (ranging in diameter from
100 to 500 μm) and subsequently transferring these 3-D colonies to suspension in serum to
induce differentiation . While the maximum frequencies of contracting aggregates
(approximately 20%) were observed in cultures initiated from 300 μm microwells, the maximum
frequency of cardiac marker myosin light chain (MLC)2A-expressing cells (approximately
3.25%) were detected in cultures initiated from 100 μm microwells. The apparently
contradictory findings in these two studies can probably be attributed to differences in methods
of aggregate formation (forced aggregation versus microwell) as well as criteria for evaluating
aggregate size (cell number versus diameter) and cardiac differentiation (contracting aggregates,
gene expression versus protein expression of cardiac markers). Furthermore, these studies were
performed using serum-based induction of differentiation which typically results in very poor
cardiomyocyte yields (< 5%) making it difficult to interpret the small differences in
differentiation efficiency between conditions. However, while significant progress still remains
to be made in developing robust methods for directing cardiac differentiation in size-controlled
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hESC aggregates, these studies do demonstrate that aggregate size influences cardiac induction
of pluripotent stem cells.
The mechanism behind the influence of aggregate size on cardiac induction is still unclear. In
size-controlled mESC aggregates generated from microwells ranging from 150 to 450 μm in
diameter, it has been observed that the effect of aggregate size on cardiac induction corresponds
to differential gene expression levels of Wnt5A and Wnt11 (Hwang, Chung et al. 2009).
Specifically, higher levels of beating and cardiac gene expression in larger aggregates (450 μm
diameter) corresponded with Wnt11 gene expression and reduced Wnt5A gene expression,
whereas smaller aggregates (150 μm diameter) expressed high levels of Wnt5A and Wnt11
expression was undetectable. The mode by which aggregate size influences the expression level
of these molecules is unclear, although the authors suggest it may be due to higher levels of
endoderm cells present in the largest aggregate size condition (450 μm diameter). It has been
recently demonstrated that varying the ratio of endoderm cells in the aggregate influences
cardiac differentiation of mESCs (Holtzinger, Rosenfeld et al. 2010). In this study, aggregates
were formed by mixing different ratios of mESCs that were transfected with a vector for
Doxycycline (Dox)-inducible overexpression of GATA-4 and the parental untransfected cell
line. In the case where GATA-4 was induced in 2-day old aggregates, enhanced cardiac
differentiation was observed with 50% GATA-4 inducible mESCs (0%, 50% and 100% GATA4-containing aggregates were examined). The cells that developed into cardiac cells were the
non-GATA-4-induced cells. GATA-4-overexpressing cells went on to express Sry-related HMG
box (SOX)17 and terminally differentiated to liver. It was concluded that the presence of these
SOX17+ cells promoted cardiac induction of the non-GATA-4 induced cells.
A number of parameters are affected by varying aggregate size. Diffusion of oxygen and
medium components becomes more limited as aggregate size increases. Observations made in
studies examining the effect of hESC colony size on pluripotency, in which larger colonies
maintained high levels of Oct4 expression while differentiation to the extra-embryonic lineage
was promoted in smaller colonies (Peerani, Rao et al. 2007), are likely relevant in a 3-D system.
The expectation being that larger aggregates would differentiate more slowly and ExE induction
would occur at a higher frequency in smaller aggregates. Geometric relationships also vary with
aggregate size, given that the ratio of the surface area to volume of a sphere decreases with
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increasing sphere size. It has been widely published in reports examining spatial organization
during EB development that one of the first events involves the organization of an outer layer of
ExE cells surrounding a pluripotent epiblast-like core (Coucouvanis and Martin 1995; Abe, Niwa
et al. 1996; Coucouvanis and Martin 1999; Rula, Cai et al. 2007; Ungrin, Joshi et al. 2008;
Moore, Cai et al. 2009). Given that as aggregate size increases, there are fewer cells on the
surface relative to interior cells, and that the outer layer of cells consists of ExE cells, it may be
that the frequency of ExE cells that develop in an aggregate decreases with increasing aggregate
size. As has been previously discussed, it has been observed during both embryogenesis and
ESC differentiation that ExE associated tissues and cell lines promote cardiac induction.
Therefore, the influence that varying aggregate size exerts on cardiac induction efficiency may
be due to directly modulating the frequency of ExE cells present.
An approach to elucidate a mechanism for the effect of hESC aggregate size on
cardiac induction efficiency
A number of studies are needed to establish whether the effect of aggregate size on cardiac
differentiation efficiency is determined by the ExE differentiation capacity of the aggregate
being related to the geometric relationship between the volume of cells on the surface of the
aggregate and the total volume of the aggregate. First, an inverse relationship between aggregate
size and endoderm frequency has to be observed during the early stages of differentiation prior to
cardiac induction. Concurrently, cardiac induction and differentiation must also be tracked with
respect to aggregate size and related to an optimal endoderm frequency during early aggregate
differentiation. The observation of a trend between aggregate size, endoderm cell frequency and
cardiac induction efficiency that is consistent with our hypothesis is, however, insufficient to
prove the hypothesis. To confirm that cardiac induction efficiency can be modulated by
controlling aggregate size via a mechanism in which aggregate size directly influences ExE cell
frequency requires an experiment in which aggregate size and ExE cell frequency is specified
independently. This may be accomplished by generating hESC aggregates with varying ratios of
ExE cells to hESCs as well as varying ratios of hESCs with impaired ability to differentiate
towards ExE to unmanipulated hESCs. To date studies exploring aggregate size control on
cardiac differentiation of hESCs have been performed in serum-containing conditions leading to
poor cardiac yields wherein small differences in differentiation efficiency between conditions are
difficult to meaningfully interpret (Burridge, Anderson et al. 2007; Mohr, Zhang et al. 2009).
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Ideally, these studies would be carried out under defined conditions that direct cardiac
differentiation (Yang, Soonpaa et al. 2008).
Inhibiting ExE differentiation of hESCs can be accomplished by knocking down genes that are
required for ExE development. In F9 embryonal carcinoma cells induced to differentiate with
retinoic acid (RA) and dibutyryl cyclic AMP (Bt2cAMP), silencing of transcription factors
GATA-4 and GATA-6 combined or SOX7 alone led to reduced expression of ExE-associated
markers SOX17 and FoxA2 and impaired development of the morphology that is characteristic
of ExE differentiation (Futaki, Hayashi et al. 2004). It appears that SOX7 activity is required
upstream of GATA-4 and GATA-6, given that SOX7 silencing led to reduced mRNA and
protein expression levels of GATA-4 and GATA-6, while GATA-4/6 silencing had little effect
on SOX7 mRNA and protein expression levels. Furthermore, exogenous expression of either
GATA-4 and GATA-6 or SOX7 in F9 clones in which SOX7 was stably silenced rescued
parietal endoderm differentiation. These observations indicated that SOX7 induces GATA-4/6
expression which is necessary for primitive endoderm development. Based on these data, one
method to impair ExE development in hESCs is to inhibit SOX7 expression. Ribonucleic Acid
(RNA) interference, used in the F9 embryonal carcinoma studies, can efficiently block
expression of the SOX7 transcription factor. The mechanism of RNA interference involves
introducing into the cell short double-stranded fragments called short interfering RNAs (siRNAs)
which are processed by an enzyme called Dicer resulting in double stranded (ds)RNA with two
to three nucleotide long overhangs on the 3’ ends. These siRNAs are then separated into single
strands and the antisense strand along with Dicer gets incorporated into the RNA induced
silencing complex (RISC). After integration into the RISC, the guide strand now guides the
entire RISC to target complementary messenger (m)RNA and induce cleavage of the mRNA,
thereby preventing it from being used as a translation template (Ahlquist 2002; Shrey, Suchit et
al. 2009).
In the studies that will be presented herein, ExE-inducible cells were obtained using SOX7overexpressing (O/E) hESCs (Seguin, Draper et al. 2008). It has recently been demonstrated that
constitutive expression of SOX7 in hESCs produces ExE progenitors (Seguin, Draper et al.
2008). SOX7 complementary (c) deoxynucleic acid (DNA) was introduced to CA1 hESCs via a
Cre-inducible expression vector. The vector consists of a CAG promoter driving expression of a
floxed bGeo-polyA followed by SOX7-puromycin (puro). Therefore, stably transfected clones
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are neomycin resistant and can be selected via treatment with geneticin (G418). Cre-transfection
of stably selected clones leads to the excision of the floxed bGeo-polyA, resulting in CAGdriven expression of SOX7 cDNA. SOX7-expressing cells can then be selected with puromycin
treatment. Within one passage of SOX7 overexpression (O/E), hESCs exhibit a flattened,
epithilial morphology and express endoderm-associated proteins GATA-4, SOX17 and alpha
fetoprotein (AFP) as well as pluripotency markers Oct4 and Nanog. Microarray-based
expression profiling revealed that, respective to No Cre controls, SOX7 O/E hESCs upregulated
ExE markers laminin subunit beta-1 (LAMB1), heparin sulfate proteoglycan (HSPG)2, and
secreted protein acidic and rich in cystein (SPARC) (Hogan, Cooper et al. 1980; Semoff, Hogan
et al. 1982; Mason, Taylor et al. 1986). Additionally, SOX7 O/E hESCs exhibited a
characteristic ExE gene expression profile which included GATA-4, GATA-6, HNF4A, FoxA2,
AFP, LAMB1, vHNF1 and SOX7, and lacked expression of definitive endoderm (DE)associated markers (CXC chemokine receptor) CXCR4, (Homeobox protein goosecoid) GSC,
and distal-less homeobox (DLX)5 and FoxQ1. Gene expression analysis suggested these cells
represent progenitors with predisposition to the ExE lineage. In an ExE differentiation assay,
using BMP4-mediated induction, relative gene expression of AFP, LAMB1, vHNF1 and SOX7
was significantly higher in SOX7 O/E hESCs compared to No Cre control hESCs. Additionally,
after 5 days of exposure to BMP4, immunoblot assays showed that SOX7 protein levels were
detected in control hESCs and were further upregulated in SOX7 O/E hESC. Flow cytometry
revealed that 87.73% of the BMP4-treated control hESC population expresses AFP. Meanwhile
in SOX7 O/E hESCs 89.13% of the cells express AFP and BMP4-treatment raises expression
frequency to 92.62%. Interestingly, while maintenance cultures of SOX7 O/E hESCs retain
expression of Oct4 and Nanog, the expression of these pluripotency markers decreases following
BMP-mediated differentiation. It has been suggested that expression of these pluripotency
markers in SOX7 O/E hESCs is involved in maintaining the precursor phenotype of these cells
by preventing terminal differentiation.
To examine the effects of controlling ExE frequency independently of aggregate size on cardiac
induction during hESC differentiation, forced aggregation of single cell suspensions in
AggrewellsTM is a system that can be easily enabled to generate aggregates with varying ratios of
SOX7 siRNA-transfected hESCs or SOX7 O/E hESCs.
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HYPOTHESIS
There is an optimal aggregate size for cardiac induction during hESC differentiation that
corresponds to the optimal frequency of extraembryonic endoderm (ExE) cells (located on the
aggregate surface) in early stage differentiating hESC aggregates.
PROJECT OBJECTIVES AND SPECIFIC AIMS
Overall goal
To develop a method to generate uniform hESC aggregates of controlled size, and further to use
this system to study the viable range of aggregate sizes for cardiac induction as well as to
elucidate a mechanism for the effect of aggregate size on cardiac induction.
Specific aim 1: Establish a technique for robust generation of uniform hESC aggregates of
controlled size.
a) Develop a technique employing micropatterning to generate uniform hESC aggregates
and control aggregate size
b) Demonstrate cardiac differentiation in micropatterned hESC aggregates
c) Examine differentiation trajectory in size-controlled hESC aggregates with respect to
MP-hESC colony and aggregate size
Specific aim 2: Enable large-scale differentiation of cardiomyocytes from MP-hESC aggregates
a) Evaluate cardiac induction in MP-hESC aggregates in a stirred suspension, oxygencontrolled bioreactor.
Specific aim 3: Reveal the effect of aggregate size on endoderm composition in early-stage
hESC aggregates and subsequently demonstrate that cardiac induction is modulated by the
endoderm composition during early hESC differentiation
a) Establish a serum-free forced aggregation based system for cardiac induction in size
controlled hESC aggregates
b) Quantitatively track ExE composition in early-stage differentiating hESC aggregates
c) Examine the effect of inhibiting ExE differentiation on the efficiency of cardiac induction
independently of hESC aggregate size.
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SUMMARY
Studies have demonstrated that aggregate size influences cardiac differentiation efficiency during
hESC differentiation. Furthermore, it has been widely observed that an ExE layer develops on
the surface of the aggregate shortly after aggregate formation. Given the inverse relationship
between aggregate size and the frequency of surface cells on the aggregate, we examined the
relationship between endoderm cell frequency and cardiac induction efficiency as a possible
mechanism behind the influence of aggregate size on cardiogenesis during hESC differentiation.
Methods were developed to control hESC aggregate size in order to investigate the hypothesis
that hESC aggregate size influenced cardiac induction by modulating the ratio of endoderm cells
during early differentiation. First, differentiation was examined in aggregates generated by
micropatterning hESC colonies at defined diameters and transferring intact colonies to
suspension in differentiation medium (Chapter 2). In this system, it was revealed that hESC
colony size affects the ratio of endoderm- to neural- associated cells in the starting population
and this ratio subsequently influences cardiac induction efficiency upon differentiation as
aggregates. Normalizing differentiation efficiency results to the ratio of endoderm to neural gene
expression in the input hESC population revealed that aggregate size does influence cardiac
induction, whereby cardiac induction is optimized in smaller aggregates when the input
population expresses higher levels of endoderm-associated genes and in larger aggregates when
the input population expresses lower endoderm gene expression levels. Furthermore, when
micropatterned aggregates (generated from 400 μm and 800 μm diameter hESC colonies) were
cultured in stirred suspension, enhanced cell yields and cardiac differentiation were achieved
compared to stirred suspension differentiation of non-size controlled EBs (Chapter 3).
Given that hESC colony size affected the input population status which influenced cardiac
induction in subsequently generated hESC aggregates, forced aggregation was implemented to
generate aggregates at different sizes from one consistent hESC population (Chapter 4). In these
studies, a clear trend emerged in which endoderm differentiation decreased with increasing
aggregate size, and cardiac induction and differentiation could be optimized by varying
aggregate size. A direct relationship between ExE frequency and cardiac differentiation was
established by generating aggregates from varying ratios of ExE progenitor cells and hESCs.
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From these studies, it was established that the influence of aggregate size on cardiac induction is
related to the frequency of endoderm cells that develop on the surface of the aggregate.
Aggregate size appears to dictate endoderm differentiation frequency in an inverse relationship
whereby the endoderm composition decreases with increasing aggregate size. We theorized that
this relationship is related to the ratio of the surface area to volume of a sphere, given that an
ExE cell layer develops on the EB surface during differentiation. Specifically, the frequency of
endoderm cells that will develop during early aggregate-based differentiation will be lower in
larger-sized aggregates. The findings in this work are significant not only towards gaining a
deeper understanding of the mechanism that guide cardiac development but also towards
improving cardiac induction efficiency during hESC differentiation and the methods developed
herein can contribute towards large scale culture of relatively enriched hESC-derived
cardiomyocytes.
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Chapter 2
Control of Human Embryonic Stem Cell Colony and
Aggregate Size Heterogeneity Influences Differentiation
Trajectories

This chapter has been published in Stem Cells. (Bauwens et al., 2008; 26(9): 2300-10). Coauthors include Raheem Peerani, Sylvia Niebruegge, Kimberly A. Woodhouse, Eugenia
Kumacheva, Mansoor Husain, and Peter W. Zandstra. Permission to reproduce this work has
been obtained from AlphaMed Press and all co-authors.
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ABSTRACT
To better understand endogenous parameters that influence pluripotent cell differentiation we
used human embryonic stem cells (hESC) as a model system. We demonstrate that
differentiation trajectories in aggregate [embryoid body (EB)]-induced differentiation, a common
approach to mimic some of the spatial and temporal aspects of in vivo development, are affected
by three factors; input hESC composition, input hESC colony size, and EB size. Using a microcontact printing approach, size-specified hESC colonies were formed by plating single cell
suspensions onto micropatterned (MP) extracellular matrix islands. Subsequently, sizecontrolled EBs were formed by transferring entire colonies into suspension culture enabling the
independent investigation of colony and aggregate size effects on differentiation induction.
Gene and protein expression analysis of MP-hESC populations revealed that the ratio of GATA6 (endoderm-associated marker) to paired box (PAX)6 (neural-associated marker) expression
increased with decreasing colony size. Moreover, upon forming EBs from these MP-hESCs, we
observed that differentiation trajectories were affected by both colony and EB size influenced
parameters. In MP-EBs generated from endoderm-biased (high GATA-6:PAX6) input hESC,
higher mesoderm and cardiac induction was observed at larger EB sizes. Conversely, neuralbiased (low GATA-6:PAX6) input hESC generated MP-EBs exhibited higher cardiac induction
in smaller EBs. Our analysis demonstrates that heterogeneity in hESC colony and aggregate
size, typical in most differentiation strategies, produces subsets of appropriate conditions for
differentiation into specific cell types. Moreover, our findings suggest that the local
microenvironment modulates endogenous parameters that can be used to influence pluripotent
cell differentiation trajectories.
INTRODUCTION
The promise of human pluripotent cells as a renewable source of specialized cells has been
limited by progress in the development of robust differentiation protocols. Since the first reports
of successful human embryonic stem cell (hESC) derivation and maintenance (Thomson,
Itskovitz-Eldor et al. 1998; Reubinoff, Pera et al. 2000), significant efforts have been made to
develop methods to control their differentiation into functional cells and tissues. The generation
of induced pluripotent stem (iPS) cells from human cells (Takahashi and Yamanaka 2006;
Takahashi, Tanabe et al. 2007; Yu, Vodyanik et al. 2007) further motivates our need to design
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controlled and reproducible mature cell production strategies. Initiating hESC differentiation
either in attached colonies or by forming embryoid bodies (EBs) has demonstrated in vitro
lineage potential in each of the three germ layers (endoderm, ectoderm, and mesoderm),
including pancreatic β-cells, neural cells, cardiomyocytes and blood cells (Thomson, ItskovitzEldor et al. 1998; Itskovitz-Eldor, Schuldiner et al. 2000; Schuldiner, Eiges et al. 2001; Xu,
Inokuma et al. 2001). Differentiation in EBs recapitulates many aspects of embryonic
development (Keller 1995). However, although it has been recognized that the developmentally
relevant emergence of specialized tissues and their subsequent differentiation to mature
functional cell types can be influenced by local inductive cues, few studies have used
microenvironmental control to prospectively regulate endogenous parameters that influence
pluripotent cell differentiation trajectories.
In the embryo it is recognized that cardiogenesis is directed via the coordination of inductive
cues from the anterior primitive endoderm (Sugi and Lough 1994; Schultheiss, Xydas et al.
1995; Sugi and Lough 1995; Schultheiss, Burch et al. 1997; Schultheiss and Lassar 1997) and
inhibitory cues originating from neurogenic tissue (Climent, Sarasa et al. 1995; Schultheiss,
Burch et al. 1997; Raffin, Leong et al. 2000). Accordingly, methods to drive mesoderm and
cardiac induction during hESC differentiation have included co-culturing hESCs with the
visceral endoderm-like cell line END-2 (Mummery, Ward-van Oostwaard et al. 2003) or the
addition of Transforming Growth Factor Beta (TGF-β) family proteins (most commonly activin
A and Bone Morphogenetic Protein (BMP)-2 or BMP-4) that are known to be secreted by
primitive endoderm (Burridge, Anderson et al. 2007; Laflamme, Chen et al. 2007). These
studies aim to exploit observations made in the embryo to direct cardiogenesis through
exogenous factor-mediated control. We hypothesize that, in addition to these exogenous factors,
endogenous parameters such as local cellularity and organization can impact in vitro hESC
differentiation. These endogenous parameters may play a role in tissue development during
embryogenesis. In this report we explore some of these parameters and document their effect on
hESC differentiation trajectories.
Many parameters can influence hESC differentiation outcome, including the handling and status
of the input hESC population, media composition, and the method of inducing differentiation
(Kitsberg 2007). Human ESC propagation typically requires paracrine and autocrine signals as
well as physical cell-cell contact (Schatten, Smith et al. 2005; Pyle, Lock et al. 2006). As a
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result, single cell dissociation is usually avoided during hESC passaging (Thomson, ItskovitzEldor et al. 1998; Amit, Carpenter et al. 2000) and hEB formation (Kehat, Kenyagin-Karsenti et
al. 2001; Xu, Police et al. 2002). Partial dissociation of hESC colonies results in a wide range of
colony and aggregate (EB) sizes. This yields a potential source of variability in subsequent
differentiation experiments (Peerani, Rao et al. 2007). Recently, control of human EB size has
been reported by a number of groups using either forced aggregation of defined cell numbers
(Ng, Davis et al. 2005; Burridge, Anderson et al. 2007; Ungrin, Joshi et al. 2008) or microwells
to form 3-D hESC aggregates of specified dimensions which can then be transferred to
suspension to form mono-disperse EBs (Khademhosseini, Ferreira et al. 2006; Mohr, de Pablo et
al. 2006). EB size may not only be an important parameter to improve reproducibility of hESC
differentiation experiments but also a potentially important parameter to regulate endogenously
influenced cell type-specific differentiation, as has been recently reported (Burridge, Anderson et
al. 2007). However, the interaction between controlling EB size and endogenously-driven cell
type-specific differentiation bias, has not been explored.
Here we detail the development of a multi-stage EB-based differentiation method to control
colony and EB size that takes advantage of the microcontact printing technique we have
previously described (Peerani, Rao et al. 2007). Using this system we demonstrate that the ratio
of endoderm- to neural-associated gene and protein expression can be manipulated as a function
of colony size, and that this ratio varies between passages in conventionally propagated hESC
cultures. Furthermore, by generating homogeneously-sized colonies and EBs we revealed that
optimizing this ratio is important for maximizing endogenous mesoderm and cardiac induction
during hESC differentiation. These data suggest that improved reproducibility and efficiency of
cell type-specific differentiation will not only require controlling colony and EB size, but also
new technologies to control and characterize the status of the hESC population prior to initiating
differentiation.
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MATERIALS AND METHODS
hESC maintenance
The H9 and H2B cell lines used in these experiments were obtained from the Israel Institute of
Technology; the use of the cells in this project has been approved by the Canadian Stem Cell
Oversight Committee. Human ESC (passages 40 to 50) colonies were maintained on irradiated
MEFs in knockout Dulbecco’s Modified Eagle’s Medium (ko-DMEM, Invitrogen) supplemented
with 20% knockout Serum Replacement (ko-SR, Invitrogen) and 4 ng/mL Fibroblast Growth
Factor (FGF)-2 (PeproTech). Passaging was performed every 4 days by dissociating the cells
into small clumps using Collagenase type IV (2 mg/mL, Invitrogen) and replating on a mouse
embryonic fibroblast (MEF) feeder layer at a subculture ratio of 1:6.
MatrigelTM Patterning
Micro-contact printing was employed to pattern MatrigelTM (BD Biosciences) onto tissue culture
surfaces. The protocol used (Figure 2.1A) to print the patterns has been adapted from a
published technique(Tan, Liu et al. 2004). Briefly, a variety of stamps, made out of
poly(dimethylsiloxane) (PDMS) using soft lithography(Younan 1998), were used for printing
different specified pattern geometries. The PDMS stamps were sterilized in 70% ethanol
overnight, inked with an aqueous solution of pH 5 1:30 growth factor reduced MatrigelTM (GFRMG) for 1 hour, rinsed with sterile ddH2O and dried with sterile N2. After rinsing and drying, a
monolayer of protein remains on the surface. This layer is transferred to the substrate by placing
the stamp in conformal contact with the substrate for more than 10 seconds. The substrates used
were tissue culture treated 60 mm dishes (Falcon). This substrate is optimal for both protein
adsorption and passivation by 5%w/v Pluronic F-127 (MW=12600Da) (Sigma) which is used to
prevent protein adsorption and cell attachment to unpatterned regions of the substrate(Tan, Liu et
al. 2004). Using this protocol, cells can be seeded on the substrate with little non-specific
binding to the passivated regions and no migration of cells between features.
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Seeding hESCs on a GFR-MGTM-patterned surface
GFR-MG was micropatterned at three feature diameters: 200, 400, and 800 μm (referred to as
200MP, 400MP, and 800MP respectively). Human ESC colonies were dissociated to single cells
using TrypLETM (Invitrogen). TrypLETM is a dissociation enzyme reagent that effectively
dissociates hESC colonies/aggregates to single cells with high viability (see Figure S1-1). Single
cell suspensions of hESC were resuspended in completely defined X-VIVO10™ medium
(Cambrex)(XV medium) with 2 mM L-Glutamine (Invitrogen), 1x nonessential amino acids
(NEAA) (Invitrogen), 0.1 M β-mercaptoethanol (Sigma) and supplemented with 40 ng/ml FGF-2
and 0.1 ng/ml TGFβ-1 (R&D Systems), and subsequently plated on the patterns at a
concentration of 1.5×106 cells/mL. Twelve hours post-seeding, the patterned cells were washed
three times with XV medium to prevent cell attachment on unpatterned areas (Figure 2.1A).
Formation and differentiation of EB aggregates from hESC colonies
To form EBs, 2 or 3 day old confluent micropatterned (MP)-hESC colonies were scraped off the
dishes gently (to preserve intact colonies), and resuspended in hESC differentiation medium
containing ko-DMEM, 20% FBS (Gibco), 1x NEAA, 2 mM L-Glutamine (Invitrogen), 0.1 M βmercaptoethanol (Sigma), and 50U/mL penicillin/streptomycin (Gibco). Cell number in hESC
colonies and suspension aggregates were measured by staining cells with a fluorescent DNA
binding dye (Cyquant, Invitrogen) and measuring average fluorescence intensity with a
fluorescence microplate reader (Spectramax Gemini). Aggregates were transferred to suspension
on ultra-low attachment non-tissue culture treated plates (Corning) for 4 days and then plated
onto 0.5% gelatin coated tissue culture treated dishes to induce cardiac differentiation in EB
outgrowths. Cultures were carried out for 16 days following EB formation. EBs formed using
published EB formation protocols served as controls (Xu, Police et al. 2002).
Quantitative analysis of EB size distribution
The number of aggregates formed was determined by manual counting on a microscope 1 day
after transferring colonies to suspension culture. To measure aggregate size distribution under
the different aggregate formation conditions, image analysis was performed with Image-Pro1
Plus software (Media Cybernetic). The number of cells per EB was determined by dissociating a
known number of EBs to single cells and counting cells.
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Flow cytometry
Pluripotency of the starting (input) hESC population was evaluated by flow cytometric analysis
of Oct4 protein expression. Human ESC colonies were enzymatically dissociated to single cells
and fixed and permeabilized with the IntraPrep fixation and permeabilization kit (Immunotech).
Fixed and permeabilized cells were incubated at a 1:100 dilution of Oct-4 antibody (Santa Cruz
Biotechnology) for 20 min at room temperature, followed by an incubation with secondary
fluorescein isothiocyanate (FITC)-conjugated IgG antibody (Molecular Probes) at a 1:100
dilution for 20 min at room temperature. Viability was assessed using 7-aminoactinomycin D
(7-AAD) (Invitrogen). Cells were analyzed with a flow cytometer (XL; Beckman-Coulter),
using EXpoADCXL4 software (Beckman-Coulter). Positive staining was defined as the
emission of a level of fluorescence that exceeded levels obtained by 99.5% of cells from the
control population stained with only the secondary antibody.
Quantitative RT-PCR analysis
Cells were digested in Trizol Reagent (Invitrogen), followed by chloroform extraction and
precipitation with iso-propyl alcohol. The RNA was then purified using RNAEasy columns
(Qiagen) with an on-column DNaseI digestion step. cDNA was generated from purified RNA by
using Superscript-III reverse transcriptase (Invitrogen) as per the manufacturer’s instructions. 10
ng of cDNA was used per PCR reaction using iQ-SYBR-green master mix (BioRad) in triplicate.
Relative expression was determined by delta-delta Ct method with the expression of beta-actin as
internal housekeeping reference (expression of GAPDH was used as a second internal
housekeeping reference). Total RNA from human fetal heart, human fetal liver, and human fetal
brain were used as positive controls (Stratagene). Primer sequences, derived from the MGH
Primerbank (Wang and Seed 2003), were as follows: Oct4 (5’ primer),
CTTGAATCCCGAATGGAAAGGG, and (3’ primer), CCTTCCCAAATAGAACCCCCA,
GATA-6 (5’ primer), AGGGCTCGGTGAGTCCAAT, and (3’ primer),
CGCTGCTGGTGAATAAAAAGGA, PAX6 (5’ primer), AAGAGCAACGTCACCAGTTTC,
and (3’ primer), GGAGCCCGGTTGATACCAG, Brachyury (5’ primer),
TGCTTCCCTGAGACCCAGTT, and (3’ primer), GATCACTTCTTTCCTTTGCATCAAG,
Mixl1 (5’ primer), CCGAGTCCAGGATCCAGGTA, and (3’ primer),
CTCTGACGCCGAGACTTGG, α-Actinin (5’ primer), GGGTCCGTTTGCCAGTCAG, and (3’
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primer), GGCTTTCCTTAGGTGGGAGTT, Nanog (5’ primer),
CAAAGGCAAACAACCCACTT, and (3’ primer), TCTGCTGGAGGCTGAGGTAT, CXCR4
(5’ primer), CACCGCATCTGGAGAACCA, and (3’ primer),
GCCCATTTCCTCGGTGTAGTT, Sox3 (5’ primer), GCCGACTGGAAACTGCTGA, and (3’
primer), CGTAGCGGTGCATCTGAGG, TroponinT (5’ primer),
GGACGAAGACGAGCAGGAG, and (3’ primer), CTTCCGGTGGATGTCATCAAA, β-actin
(5’ primer), CATGTACGTTGCTATCCAGGC, and (3’ primer),
CTCCTTAATGTCACGCACGAT, GAPDH (5’ primer), CTCCACGACGTACTCAGCG, and
(3’ primer), TGTTGCCATCAATGACCCCTT. Specificity of amplification was assured with
analysis of dissociation curves of all reactions. For all samples a control was performed without
reverse transcriptase and no amplification was detected in these controls.
Immunostaining analysis
Fluorescent images of α-Actinin (EA-53, 1:800, Sigma), Connexin-43 (1:25, Molecular Probes),
GATA-6 (1:20, R&D Systems) and Oct4 (1:200, Santa Cruz Biotechnology) protein expression
were obtained and quantitatively analyzed using the Compartmental Analysis or Target
Activation assay algorithms available with the Cellomics Arrayscan VTI platform (Cellomics).
Statistics
To evaluate differences in gene expression level between conditions, statistics were manually
computed using the Wilcoxon signed rank test for a paired difference experiment at a
significance level of P < 0.05. To evaluate differences in EB size between conditions, statistics
were computed in Origin 7.5 using the paired t-test at a significance level of P < 0.05. Error bars
on plots represent the standard deviation of the mean of three or more replicates (n>3).
RESULTS
An approach for generating size-controlled hESC colonies and EBs
Typically, EB-based hESC differentiation involves partial enzymatic dissociation of hESC
colonies resulting in a suspension of cell clumps of varying sizes (Figure 2.1B). We have
developed a process, illustrated in Figure 2.1A, for generating uniform EBs of controlled size
based on micropatterning hESC colonies at defined diameters. Briefly, hESC colonies are
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dissociated to single cells and replated at high density onto micropatterned MatrigelTM islands.
Upon confluence, MP-hESC colonies are transferred to suspension culture by detaching them
intact with a cell scraper and resuspending the colonies in hESC differentiation medium. Figure
2.1C depicts the overall approach, outlining three aspects of this system which could affect
endogenous control of differentiation trajectory: 1) Status of the input hESC population; 2)
Micropatterned (MP)-hESC colony size; and 3) MP-EB size.
Even under maintenance conditions, hESC cultures do not consist of a homogeneous pluripotent
population but contain hESC-derived differentiated cells (Henderson, Draper et al. 2002;
Furusawa, Ohkoshi et al. 2004). Therefore the composition of the input hESC population varies
between passages and could impact cell fate trajectory during differentiation. Colony size is also
an important parameter in determining self-renewal and differentiation fate, as hESC
maintenance relies on paracrine signaling from neighboring undifferentiated cells to antagonize
pro-differentiation signals (Peerani, Rao et al. 2007). Finally, EB size could affect
differentiation as control of this parameter may modulate spatial signaling within the aggregate.
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Figure 2.1: Overview of conventional and micropatterned (MP) hESC colony and EB formation. (A) Outline
of the process for micropatterning MatrigelTM (MG) on a cell culture substrate, and subsequently seeding cells onto
MG-patterned substrate. (B) In conventional EB formation, hESC colonies (input hESC) are enzymatically
dissociated to cell clumps and transferred to ultra-low attachment tissue culture plates in hESC differentiation
medium. (C) To generate size-controlled colonies, hESCs are dissociated to single cells and plated at high density
(1×106 cells/mL) onto patterned MatrigelTM islands and cultured to confluence (2-3 days) in serum-free maintenance
medium. To form MP-EBs, intact colonies are detached using a cell scraper and transferred to suspension in
differentiation medium. Scale bar = 250 μm

The influence of colony size on differentiation trajectory in MP-hESC colonies
To evaluate the effect of colony size on differentiation trajectory, hESC colonies were patterned
at three diameters (Figure 2.2A): 200, 400 and 800 μm (200MP, 400MP, and 800MP
respectively). Additionally, non-patterned (non-MP) conventional hESC colonies were cultured
in parallel for comparison. A flow cytometry analysis of six separate input hESC populations
demonstrates that in each run the majority of cells express the pluripotency protein Oct4 with
expression frequencies ranging from 57% to 78.4% in six independent input populations (Figure
2.2B). To determine the effect of colony size on differentiation trajectory, quantitative
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(q)RTPCR was performed to compare gene expression levels between input hESC populations
and their corresponding day 2 or 3 colony size-controlled, micropatterned (MP)-hESC
derivatives. Oct4, GATA-6, and PAX6 gene expression levels were tested as a surrogate
measure for undifferentiated cells, endodermal and neural differentiation/commitment
respectively. Importantly, these trends were reproduced with a second gene set [Nanog for
undifferentiated cells, CXCR4 for endoderm, and Sox3 for neural (Figure S1-2)]. As
demonstrated in the three representative runs shown in Figure 2.2C, variability in lineagespecific gene expression in the input-hESC population led to variability in gene expression in the
MP-hESC populations. Despite variations between runs, similar trends were observed in each
run in terms of the effect of colony size on gene expression level (see Table 2-I for statistical
validation of these trends). Non-MP hESCs expressed similar levels of expression for all three
genes as the input hESC populations, thus demonstrating that the process of passaging onto
MatrigelTM in serum-free medium itself does not skew the population. Non-MP and 200MP
colonies maintained the Oct4 gene expression level of their input hESC, whereas a significant
increase in Oct4 gene expression levels was observed in the larger colonies (400MP and
800MP). It should be noted that our gene expression analysis detects the Oct4A and Oct4B
isoforms. It has recently been reported that expression of the Oct4B isoform is not exclusive to
undifferentiated ESCs and is predominantly expressed in the cytoplasm (Lee, Kim et al. 2006).
Using immunofluorescence, we have demonstrated that Oct4 protein expression in the input
hESC population is localized in the nucleus (Figure S1-3), suggesting that we are measuring
Oct4A isoform expression. Compared to input hESCs, the GATA-6 gene expression level was
maintained in non-MP hESCs. In MP-hESCs, expression of this endoderm marker rose
significantly in small colonies (200MP), with gene expression level decreasing as colony size
increased. Conversely, PAX6 gene expression levels suggest that markers of neural
differentiation rise significantly in larger colonies (400MP and 800MP) than in smaller colonies
(200MP) (Table 2-I). We followed the gene expression analysis with an examination of protein
expression of these markers in our MP-hESC colonies. The frequency of Oct4 proteinexpressing cells was similar at each colony size (Figure 2.2E), ranging between 80 to 85%,
despite increasing Oct4 gene expression with increasing colony size. Conversely, GATA-6
protein expression frequency, consistent with the GATA-6 gene expression data, was
significantly higher in the small 200MP colony condition (55 to 60%). PAX6 protein expression
was not detectable at this stage of differentiation. Interestingly, while GATA-6 and Oct4 co-
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expression was observed in the small 200MP colonies (Figure 2.2D-i), in the larger 400MP and
800MP hESC colonies co-expression was generally not observed (Figure 2.2D-ii and 2.2D-iii).
These data suggest that controlling colony size can impact changes in gene expression in cells
that still express pluripotency markers to skew the probability of the cells taking one
differentiation trajectory over another.
Next, we employed an analysis of the ratio of endoderm-to-neural gene expression levels
(GATA-6:PAX6) in the input hESC and output MP-hESC populations to investigate
relationships between colony size and differentiation trajectory with respect to the input hESC
composition (Figure 2.3A). In runs initiated with intermediate input GATA-6:PAX6 ratios
between 0.35 and 0.55 (i.e. a “balanced” population), it was observed that the output MP-hESC
ratio of endoderm (GATA-6) to neural (PAX6) gene expression was always higher than the input
hESC ratio, and that GATA-6:PAX6 decreased with increasing colony size. Input hESC
populations with GATA-6:PAX6 ratios that were at high (> 0.55) and low (< 0.35) extremes
resulted in almost no change in GATA-6:PAX6 ratio in the non-MP, 400MP and 800MP
conditions, possibly indicating that these ratios represent cell populations that are not easily
manipulated. The smallest colony condition (200MP) displayed an increase in the GATA6:PAX6 ratio post-MP regardless of the input hESC ratio. The increase in endoderm gene
expression post-MP in the 200MP condition may be attributed to the rapid differentiation of
hESCs occurring at low localized cell densities (localized cell density refers to the number of
cells per unit radius; in this case the number of cells per 500 µm radius). Not surprisingly, nonMP colonies showed no changes in ratios after a conventional passage was performed in parallel
with the patterned conditions. As illustrated in Figure 2.3B, these results reveal two important
parameters that affect differentiation trajectory in this system, input hESC composition and MPhESC colony size. Schematically, input hESCs typically display a range of GATA-6 and PAX6
expressions levels (Figure 2.3B-i), which subsequently shift upon micropatterning according to
colony size. In these studies it was observed that larger colonies support enrichment of neuralfated cells while smaller colonies support the enrichment of endoderm-fated cells (Figure 2.3Bii).
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Figure 2.2: Analysis of size controlled MP-hESC colonies reveals the influence of colony size on
differentiation trajectory. (A) Bright field images, at high (top panel) and low (bottom panel) magnification, of
non-patterned (non-MP) hESC colonies and colonies patterned at 200, 400 and 800 µm diameters (200MP, 400MP,
and 800MP respectively). Scale bars = 250 μm. (B) Representative flow cytometry results of input hESC Oct4
protein expression from six independent runs. Blue: Oct4-stained population. Percentages indicate frequency of
positive-staining cells compared to secondary antibody control (red). (C) Representative qRTPCR analysis for 3
out of 7 trials for expression of Oct4, Gata6, and Pax6 (Collective results of all trials found in Table 2-I). (D)
Immunofluorescence images displaying Oct4 (red) and Gata6 (green) protein expression in 200MP (i), 400MP (ii)
and 800MP (iii) colonies. Hoechst was used as a nuclear stain. Scale bars represent 175 μm. (E) Gata6 and Oct4
protein expression frequencies in 200MP, 400MP, and 800MP hESC colonies.
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TABLE 2-I. Gene expression level ranges of pre-patterned (Input hESC) and postpatterned (Non-MP and MP-hESC) hESC cultures (n=7)
Mean (Range) Gene Expression Levela
Oct4

Gata6

Pax6

Input hESC

0.33 (0.16-0.71)

0.27 (0.20-0.43)

0.77 (0.36-0.98)

Non-MP

0.32 (0.11-0.58)

0.24 (0.11-0.48)

0.77 (0.66-0.94)

200MP

0.37 (0.25-0.61)

1.11 (0.54-1.78)b, c

0.42 (0.32-0.51)b, c

400MP

0.65 (0.26-1)b, c, d

0.42 (0.03-1.00)d

0.68 (0.44-0.99)d

800MP

0.66 (0.21-0.97) b, c, d

0.19 (0.0045-0.48)d, e

0.66 (0.36-0.92)d

a

When significant differences exist they are displayed for each condition with conditions in previous row
differs significantly from input hESC
c
differs significantly from non-MP
d
differs significantly from 200MP
e
differs significantly from 400MP
b
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Figure 2.3: Gata6 to Pax6 gene expression ratios in MP-hESC cultures are influenced by input hESC
composition and colony size. (A)The effect of (output) MP-hESC colony size on the gene expression ratio
Gata6:Pax6 with respect to the corresponding input hESC Gata6:Pax6. (B) Schematics illustrating (i) variations in
distribution of Gata6:Pax6 gene expression ratios between each input hESC populations (I), and (ii) the relationship
between the Gata6:Pax6 gene expression ratio of any given Input hESC population (I, dotted line) and its
corresponding MP-hESC Gata6:Pax6 ratios at each colony size (200MP, 400MP, and 800MP, solid lines).

The influence of colony size on differentiation trajectories in hESC-derived EBs
To evaluate our ability to control EB size using our patterning method, image analysis was
performed on light microscopy images of day 1 EBs (Figure 2.4A) to calculate size distributions
based on EB diameter. Narrower size distributions were observed in MP-EB cultures compared
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to non-MP EB cultures. Furthermore, significantly different EB size distributions were observed
between EB cultures generated from each hESC colony size examined (200MP, 400MP, and
800MP) (Figure 2.4B-i). In addition to EB diameter, colony and aggregate size control was also
evaluated using a fluorescent DNA method (Cyquant, Invitrogen) to measure cell number
(Figure 2.4B-ii). This analysis demonstrated that the number of cells in each colony is
comparable to the number of cells in each aggregate upon EB formation. Furthermore, based on
cell number, significant differences in EB size were observed between 200MP and 800MP, and
400MP and 800MP (Figure 2.4B-ii).
Within the EB, differentiation is guided by spatial cues and interactions between various cell
types. Accordingly, it is probable that the specific composition (or gene expression status) of the
hESC population used to initiate EBs is an influential factor in determining cell fate during EB
development. Given that mesoderm commitment and cardiogenesis in the embryo is thought to
be regulated through coordinated inductive and inhibitory signals from neighboring endoderm
(Schultheiss, Xydas et al. 1995; Sugi and Lough 1995; Zhu, Sasse et al. 1999) and neural tissue
respectively (Marvin, Di Rocco et al. 2001; Tzahor and Lassar 2001), and that the ratio of
neural- and endoderm-associated gene expression in hESC cultures can be manipulated by
varying colony size, we next examined if this ratio influenced mesoderm and cardiac induction
in size-controlled EBs. Using qRTPCR, mesoderm- (Brachyury (Bry) and Mixl1) and cardiac(α-Actinin) associated gene expression levels were measured in EB outgrowths eight days (day
8) after EB formation. Brachyury is transiently expressed in early mesoderm (Hakuno,
Takahashi et al. 2005), and has been shown to be expressed at elevated levels between day 4 and
day 10 of EB differentiation (Bettiol, Sartiani et al. 2007; Kolodziejska, Ashraf et al. 2008).
Mixl1 is expressed in the primitive streak (Pearce and Evans 1999; Robb, Hartley et al. 2000),
and in hESC-derived EBs from day 3 to day 10 (Pick, Azzola et al. 2007). α-Actinin is a cardiac
contractile protein gene that has also been detected in differentiating hESC-derived EBs by day
12 (Passier, Oostwaard et al. 2005; Beqqali, Kloots et al. 2006). Plotting gene expression levels
of day 8 EB outgrowths with respect to the neural and endoderm composition of their starting
MP-hESC populations (Figure 2.5A) revealed similar expression profiles for both mesoderm and
cardiac markers. It was observed that gene expression levels of all mesoderm and cardiac
markers examined were maximized in 400MP and 800MP EBs generated from MP-hESC
populations with GATA-6:PAX6 expression level ratios above 0.1 (Figure 2.5A), whereas gene
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expression was virtually undetectable in EBs generated from neural-enriched MP-hESCs
(GATA-6:PAX6 < 0.01, mostly 800MP) and endoderm-enriched MP-hESCs (GATA-6:PAX6 >
1, 200MP colonies). Non-MP cultures gave rise to starting population compositions across the
range observed for cardiac gene induction in MP-hESC cultures (0.1 to 1); however resulted in
notably lower gene expression levels for all mesoderm and cardiac differentiation markers, likely
due to heterogeneity in responsiveness. Given that non-MP EBs were generated from non sizecontrolled hESC colonies (Figure 2.2A) the measured GATA-6 and PAX6 gene expression
levels for non-MP hESCs represent an average of different colony (Figure 2.4B) sizes with
varying ratios of endoderm-fated and neural-fated cells. While the average GATA-6:PAX6 ratio
for the non-MP condition falls within the optimum range for cardiac induction, it includes high
ratios for small GATA-6-expressing colonies and low ratios for large PAX6-expressing colonies
which were observed to result in poor cardiac induction (Figure 2.5B).

Figure 2.4: Formation of size-controlled MP-EBs. (A) Bright filed images of EBs generated under the 4
conditions tested: non-patterned colonies (non-MP) and colonies patterned at 200, 400 and 800 µm diameters
(200MP, 400MP, and 800MP respectively). Scale bars = 250 μm. (B) Quantitative demonstration of EB size
control in EBs generated from size-controlled hESC colonies by (i) EB diameter, and (ii) by comparing cell number
in colonies to cell number in subsequently generated aggregates using fluorescent DNA staining.
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Figure 2.5: The interactive effect of MP-hESC colony size and cell composition on mesoderm and cardiac
induction in MP-EBs. (A) Gene expression levels measured for mesoderm markers Brachyury (Bry) and Mixl1,
and cardiac marker α-Actinin in day 8 (d8) EBs plotted with respect to the Gata6:Pax6 gene expression ratio in the
corresponding MP-hESC starting population, and as a function of MP-hESC colony size. Neural-enriched and
endoderm-enriched starting MP-hESCs generate MP-EBs that display poor mesoderm and cardiac induction, as
indicated by the marked regions on the plots. (B) A schematic summarizing the observed effect of controlling
colony size on MP-hESC composition, and the consequence of MP-hESC composition on cardiac induction.

Mature cell differentiation in MP-EBs and the effect of input hESC composition
and colony/EB size on cardiac induction
Starting at day 8 of EB culture, contracting areas appeared in MP-EB outgrowths suggesting that
these cells exhibit spontaneous electrical activity. Optical mapping with di-4-ANEPPS
demonstrated that changes in membrane potential corresponded visually with contractions (data
not shown). Immunostaining revealed positive expression of contractile protein markers αsarcomeric actin (α-SR-1) and α-Actinin (EA-53), as well as the gap junction protein Connexin43 (Cx-43) (Figure 2.6A). Staining day 20 EB outgrowths with α-SR-1 demonstrated a cluster of
cardiac cells, whereas EA-53 expression in day 20 replated single cells exhibited the clear
cardiac morphology of striated, highly organized fibers. Immunofluorescence analysis of Cx-43
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expression on day 22 from dissociated MP-EBs that had been replated at high density displayed
a web-like pattern of staining highly concentrated between cell membranes, indicating functional
cell coupling.
To quantitatively evaluate mature differentiation from MP-EB induced differentiation cultures,
day 16 MP-EB outgrowths were dissociated to single cells and cultured for 2 days as a
monolayer on fibronectin-gelatin coated plates and then immunostained with EA-53 to detect
cardiac differentiation. Quantitative immunofluorescence was used to image the cells and detect
positive protein expression, revealing the presence of EA-53+ cardiomyocytes (Figure 2.6B).
The effect of MP-EB size and MP-hESC composition (level of GATA-6 and PAX6 gene
expression) on cardiomyocyte frequency was analyzed. In runs initiated from neural-enriched
MP-hESC populations (high-PAX6/low-GATA-6 gene expression), higher frequencies of EA-53
expression were observed in smaller MP-EBs (Figure 2.6C-i). Conversely, in runs initiated from
endoderm-enriched MP-hESC populations (low-PAX6/high-GATA-6 gene expression), the
frequency of EA-53 expression was higher in larger MP-EBs (Figure 2.6C-ii). Additionally,
tracking the appearance of beating areas and neural rosettes in the MP-EB cultures (Figure
2.6D), it was observed that within individual runs, neural rosettes were always present in larger
EB sizes than those in which beating areas were detected. But between runs, the specific MP-EB
size that gave rise to the appearance of neural rosettes or beating areas shifted. A proposed
mechanism for our observations is summarized in Figure 2.6E, wherein, mirroring what happens
upon manipulating hESC colony size, the endoderm composition is higher in smaller MP-EBs
and is lower in larger MP-EBs, however the specific MP-EB size that optimizes cardiac
induction shifts based on the cell composition of the input hESC population.
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Figure 2.6: MP EBs can be used to form mature cell types and the output is dependent on colony and EB
size. (A) Immunostaining on a replated monolayer demonstrated expression of (i) alpha sarcomeric actin (α-SR-1) in
day 21 (d21) EB outgrowths, (ii) α-actinin (EA-53) at day 20, and (iii) gap junction protein Cx-43 at day 22. (B)
Representative α-Actinin immunofluorescence images from Cellomics analysis i) demonstrating the algorithm used
to detect positive α-Actinin, and (ii) the corresponding overlay image. (C) A comparison of α-Actinin-expression
frequency at two EB sizes (400MP and 800MP) from independent runs initiated with either a neural-enriched
(Gata6-low/Pax6-high) or an endoderm-enriched (Gata6-high/Pax6-low) MP-hESC population. (D) Tracking
neural rosettes and spontaneously contracting areas in day 8 EBs (3 representative trials). (E) The observed effect
of differences in endoderm and neural cell composition in the input hESC population that are further modulated in
MP-hESC by controlling colony size, and ultimately impact MP-EB-based cardiac induction.
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DISCUSSION
EB-based differentiation is a powerful system because it can mimic in vivo embryonic
development and provides a platform to study the effects of cell-cell interactions and spatial
organization on cell type-specific commitment. During embryogenesis, factors secreted by
anterior lateral endoderm are thought to direct cardiac differentiation of neighboring mesoderm,
as well as to promote cell survival and proliferation (Schultheiss, Xydas et al. 1995; Sugi and
Lough 1995; Antin, Yatskievych et al. 1996; Zhu, Sasse et al. 1999), while parietal endoderm
(Stary, Schneider et al. 2006) and visceral endoderm (Hogan, Taylor et al. 1981; Mummery,
Ward-van Oostwaard et al. 2003; Bin, Sheng et al. 2006) have been shown to enhance ESC
differentiation to cardiomyocytes. Given that one of the first events in EB development is the
formation of an endoderm layer surrounding a pluripotent epiblast core (Keller 1995; Grabel,
Becker et al. 1998), we hypothesized that controlling EB size would modulate the ratio of
cardiac-inducing visceral endoderm cells to pluripotent hESCs within the EB proportionally to
the surface area (endoderm) to volume (hESC) ratio of the EB. In other words, we expected that
the endoderm:hESC ratio would decrease with increasing EB size. Accordingly, there would be
an ideal EB size corresponding to the ideal ratio of endoderm cells to hESCs to optimize cardiac
induction.
A number of groups are targeting EB size control to improve hESC differentiation (Ng, Davis et
al. 2005; Khademhosseini, Ferreira et al. 2006; Mohr, de Pablo et al. 2006; Burridge, Anderson
et al. 2007). One limitation of our system is that EBs are formed from 2-dimensional colonies
prior to transferring them to suspension. Ultimately, it would be advantageous if the cell
trajectory control we have in our 2-D system can be translated to direct methods for 3dimensional cell patterning (Khademhosseini, Ferreira et al. 2006; Mohr, de Pablo et al. 2006).
We observed that controlling EB size (Rosenthal, Macdonald et al. 2007) alone was insufficient
to achieve reproducible cardiac induction. In fact, comparing cardiac induction in separate EB
size-controlled runs with respect to EB size alone yielded more variability than in parallel non
size-controlled runs, with no clear pattern between EB size and cardiac induction efficiency. It
became apparent that EB size-controlled cultures were more sensitive to differences in the
starting population, which is typically comprised of cells expressing pluripotent hESC markers
and markers of early hESC derivatives. We thus concluded that analyzing the expression of
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pluripotency markers (Oct4, Nanog) was inadequate for assessing the input population, and that
the composition of cell types expressing markers associated with lineage commitment are useful
indicators for differentiation trajectory biases. Interestingly, using quantitative image analysis,
we have observed both the co-expression and unique expression of pluripotency markers and
differentiation associated markers at the protein level. This data suggest that both cell-cell
interactions and endogenous parameters influence cell differentiation trajectories. In our system
the effect of EB size on mesoderm/cardiac induction was dependent on the ratio of endodermgene expressing to neural-gene expressing cells. Importantly, this ratio could exist at a wide
range of values within an input hESC population expressing robust levels of typical
pluripotency-associated markers. While signals from neighboring endoderm promote cardiac
induction, we did not observe an increase in cardiac induction in endoderm marker expression
enriched starting populations, which demonstrates the necessity to balance the ratio of
undifferentiated cells and endoderm/endoderm precursor cells in differentiating EBs. Input
populations exhibiting high endoderm-associated marker expression produced differentiation
cultures with increased mesoderm/cardiac induction in larger EBs, while neural-marker enriched
input populations resulted in increased mesoderm/cardiac induction in smaller EBs. This
observation corresponds with our previously stated hypothesis that you can modulate the ratio of
outer endoderm cells and inner hESCs by controlling EB size; however this ratio is also a
function of the initial ratio of endoderm-associated and neural-associated cells in the hESC
population prior to initiating micropatterned colonies.
Controlling the EB size revealed that hESC differentiation studies are hampered by variations in
the gene expression profiles of hESC input populations. Our data suggests that colony size can
be manipulated to generate the appropriate input cell composition for increased
mesoderm/cardiac induction efficiency during EB-mediated hESC differentiation. The ratio of
endoderm to neural precursors may be an indicator of an input population’s mesoderm/cardiac
induction efficiency because, as previously discussed, endoderm is believed to secrete procardiogenic factors while signals (such as Wnts) from the neural tube have been shown to block
heart formation in the embryo (Marvin, Di Rocco et al. 2001; Tzahor and Lassar 2001). By
micropatterning hESC colonies of defined diameters, we demonstrated that the level of
pluripotency gene expression as well as the ratio of endoderm-associated to neural-associated
cells is a function of colony size (Figure 2.3). Larger colonies exhibit higher levels of expression
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of pluripotency genes (Oct4 and Nanog) and lower ratios of endoderm-associated to neuralassociated cells, while smaller colonies exhibit lower expression levels of pluripotencyassociated genes and higher ratios of endoderm-associated to neural-associated cells. These
observations are consistent with the literature including our previous report that enhanced
maintenance of the hESC phenotype in larger colonies was attributable to an antagonistic
interaction between secreted factors from pluripotent and extra-embryonic endoderm cells that
regulates Small mothers against Decapentaplegic (Smad)1 activation (Peerani, Rao et al. 2007).
In a larger colony, the higher local cell density (cell number per unit radius) leads to higher
levels of BMP antagonists (such as GDF3), which are secreted by hESCs, thereby supporting self
renewal by suppressing Smad1 activation. Meanwhile in smaller colonies, with lower local
hESC densities, the secretion of BMP2 by extra-embryonic endoderm activates Smad1 thus
suppressing self renewal. Further, it has been demonstrated that strong interference of
endogenous BMP-2 signaling in hESC cultures leads to the induction of cells expressing the
characteristic neuroectoderm markers Pax-6 and nestin (Pera, Andrade et al. 2004). Therefore,
in smaller colonies (low local cell densities) lower levels of BMP-2 antagonist factor promote
endoderm differentiation (higher GATA-6:PAX6), while in larger colonies (higher local cell
densities) higher levels of BMP-antagonist suppress endoderm differentiation leading to higher
levels of Oct4 and PAX6 expression.
In conclusion, our findings here have revealed three critical parameters currently neglected in
most hESC differentiation experiments: (1) the status of the input hESC composition, (2) hESC
colony size, and (3) EB size. Specifically, reproducible, efficient (endogenous)
mesoderm/cardiac induction is dependent on (1) the ratio of endoderm to neural precursors in the
input hESC population, which (2) can be modulated by controlling hESC colony size, as well as
on (3) EB size possibly through a mechanism in which size modulates the ratio of endoderm
cells to hESCs during EB development prior to the mesoderm/cardiac induction phase. In
combination with future approaches aimed at selecting input hESC populations with more
permissive gene expression profiles for specific differentiation trajectories, we posit that micropatterning will enable more rigorous optimization of other tissue environment factors that depend
on colony- and EB- size.
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Chapter 3
Generation of Human Embryonic Stem Cell-Derived Mesoderm
and Cardiac Cells Using Size-Specified Aggregates in an
Oxygen-Controlled Bioreactor

This chapter has been published in Biotechnology and Bioengineering. (Niebruegge et al., 2009;
102(2): 493-507). Contributions by Céline Bauwens include development of methods to control
EB size by micropatterning hESCs, bioreactor protocols, and design of hypoxia studies. Coauthors include Sylvia Niebruegge, Raheem Peerani, Nimalan Thavandiran, Stephane Masse,
Elias Sevaptisidis, Kumar Nanthakumar, Kimberly A. Woodhouse, Mansoor Husain, Eugenia
Kumacheva, and Peter W. Zandstra. Permission to reproduce this work has been obtained from
Whiley-Blackwell and all co-authors.
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ABSTRACT
The ability to generate human pluripotent stem cell-derived cell types at sufficiently high
numbers and in a reproducible manner is fundamental for clinical and biopharmaceutical
applications. Current experimental methods for the differentiation of pluripotent cells such as
human embryonic stem cells (hESC) rely on the generation of heterogeneous aggregates of cells,
also called “embryoid bodies” (EBs), in small scale static culture. These protocols are typically
(1) not scalable, (2) result in a wide range of EB sizes and (3) expose cells to fluctuations in
physicochemical parameters. With the goal of establishing a robust bioprocess we first screened
different scalable suspension systems for their ability to support the growth and differentiation of
hESCs. Next homogeneity of initial cell aggregates was improved by employing a microprinting strategy to generate large numbers of size-specified hESC aggregates. Finally, these
technologies were integrated into a fully controlled bioreactor system and the impact of oxygen
concentration was investigated. Our results demonstrate the beneficial effects of stirred
bioreactor culture, aggregate size-control and hypoxia (4% oxygen tension) on both cell growth
and cell differentiation towards cardiomyocytes. QRT-PCR data for markers such as brachyury,
LIM domain homeobox gene Isl-1, Troponin T and Myosin Light Chain 2v, as well as
immunohistochemistry and functional analysis by response to chronotropic agents, documented
the impact of these parameters on cardiac differentiation. This study provides an important
foundation towards the robust generation of clinically relevant numbers of hESC derived cells.
INTRODUCTION
Embryonic and pluripotent stem cells are capable of self renewal and multilineage differentiation
(Evans and Kaufman 1981; Thomson, Itskovitz-Eldor et al. 1998). The ability of human
embryonic stem cells (hESC) to differentiate to specialized cells including neural progenitor
cells, cardiomyocytes and insulin producing cells (Carpenter, Inokuma et al. 2001; Gerecht-Nir,
Fishman et al. 2004; Segev, Fishman et al. 2004) underpins excitement in the use of these cells
for accelerating drug discovery and developing new cellular therapeutics. Cardiomyocytes and
cardiac progenitors, generated either through embryoid body (EB) formation (Kehat, KenyaginKarsenti et al. 2001; Xu, Police et al. 2002; Huber, Itzhaki et al. 2007; Leor, Gerecht et al. 2007),
coculture (Mummery, Ward-van Oostwaard et al. 2003; Passier, Oostwaard et al. 2005; Bin,
Sheng et al. 2006) or serum-free cytokine induction (Li, Powell et al. 2005; McDevitt, Laflamme
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et al. 2005; Passier, Oostwaard et al. 2005; Kattman, Huber et al. 2006; Ludwig, Bergendahl et
al. 2006; Xu, He et al. 2006; Kattman, Adler et al. 2007; Laflamme, Chen et al. 2007; Yang,
Soonpaa et al. 2008; Zhang, Li et al. 2008), have been successfully derived from hESC. These
cells exhibit many of the properties of native cardiac cells including electrophysiological
responsiveness (Kehat, Gepstein et al. 2002; He, Ma et al. 2003; Satin, Kehat et al. 2004; Xue,
Cho et al. 2005; Binah, Dolnikov et al. 2007) and in vivo function (Kehat, Khimovich et al.
2004; Xue, Cho et al. 2005; Moon, Park et al. 2006). Recent animal models with ESC-derived
cardiomyocytes of mouse and human origin support the potential of this cell source for heart
repair (Kehat, Khimovich et al. 2004; Laflamme, Gold et al. 2005; Menard, Hagege et al. 2005;
Kolossov, Bostani et al. 2006; Caspi, Huber et al. 2007; Dai, Field et al. 2007; Ebelt, Jungblut et
al. 2007; Leor, Gerecht et al. 2007). This promising technology, however, is limited by the
number of cells that will be required to manufacture a cardiac cell patch, or to replace damaged
tissues. It is estimated that in a typical cardiac infarct as many as one billion cardiac cells die
(Murry, Reinecke et al. 2006); their replacement may enable the structural and functional healing
of an adult heart.
Although bioprocesses for mouse (m)ESC propagation and differentiation have been well
established (Keller 1995; Kurosawa, Imamura et al. 2003; Bauwens, Yin et al. 2005; Fok and
Zandstra 2005; Schroeder, Niebruegge et al. 2005), the translation of these technologies to
hESCs has been challenging, principally because hESC growth rates have been slower, and
heterogeneity in culture and media formulations have limited optimization of differentiation
efficiencies and population expansions. Progress has been made in the development of
engineered systems to generate hESC-derived cells, including stirred and rotating cultures for
hESC differentiation (Gerecht-Nir, Cohen et al. 2004; Cameron, Hu et al. 2006) and hESC
growth in microbioreactors or matrices (Figallo, Cannizzaro et al. 2007; Gerecht, Burdick et al.
2007). However these systems typically do not control the microenvironment that the cells are
exposed to or regulate heterogeneity in cellular parameters such as aggregate size. In recent
studies we have demonstrated that the rate and trajectories of hESC differentiation can be
controlled by engineering hESC niche properties using a robust micropatterning-technology
(Peerani, Rao et al. 2007; Bauwens, Peerani et al. 2008). This technique provides an important
strategy towards micro-environmental regulation and directed differentiation, which we have
utilized here for the formation of size-controlled aggregates of hESCs.
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Cell fate decisions can also be influenced by cell extrinsic factors such as cell-cell interactions,
soluble factors and physicochemical parameters. Low oxygen tension (2-5%) has been shown to
enhance mouse and human ESC proliferation (Forsyth, Musio et al. 2006; Gibbons, Hewitt et al.
2006), and we have previously used this parameter to enhance cardiac differentiation from
mESCs (Zandstra, Bauwens et al. 2003; Bauwens, Yin et al. 2005). It is further noteworthy that,
during embryogenesis and particularly during the development of the cardiovascular system,
many cues and processes are influenced by hypoxia (Ramirez-Bergeron and Simon 2001;
Ramirez-Bergeron, Runge et al. 2004; Buggisch, Ateghang et al. 2007).
By combining both tools, engineering the cellular microenvironment using micropatterningbased aggregate control and physicochemical (oxygen) control using bioreactors, we here report
a novel two-step bioprocess for the generation of human pluripotent cell-derived mesoderm and
cardiac cells in a stirred suspension system. Quantitative RT-PCR, immunohistochemistry and
functional analysis using optical mapping demonstrated the capacity of this system to generate
ESC-derived cells including cardiomyocytes. This approach forms an important foundation for
the development of scalable and controllable bioprocesses for pluripotent cell expansion and
differentiation.
METHODS
hESC maintenance
Human ESC (H9, passages 37 to 52; HES2, passages 24 to 26) were routinely maintained on
irradiated feeder-layers of mouse embryonic fibroblasts (mEFs) in KnockOut (ko)-Dulbecco’s
Modified Eagle Medium (DMEM, Invitrogen) with 20% ko-Serum Replacement (SR)
(Invitrogen) and supplemented with 4 ng/mL FGF-2 (PeproTech). Cells were dissociated into
small clumps using 0.1 % collagenase IV (Invitrogen) and passaged every 7 days. For passaging,
plates were incubated with Collagenase type IV (2 mg/mL, Invitrogen) for 10 min. After
aspirating, the collagenase was replaced with hESC maintenance medium. The colonies were
then scraped-off the dish and gently pipetted to generate small cell clumps that were replated on
a mEF feeder layer at a subculture ratio of 1:6. Karyotype results for H9 cells are provided in
Supplementary Figure 1.
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Formation of EBs
Before forming EBs from hESC maintained on mEFs, cells were pre-differentiated by replacing
maintenance medium with differentiation medium: 20% fetal bovine serum (Hyclone), 0.1 mM
β-mercaptoethanol (Sigma), 0.1 mM non-essential amino acids (NEAA), 2 mM L-glutamine, 50
U/mL penicillin, and 50 µg streptomycin in ko-DMEM (all from Gibco). After 24 h cells were
incubated with collagenase type IV (2 mg/mL, Invitrogen) for 10 min and then the collagenase
was replaced by differentiation medium. To initiate EB formation cells were scraped-off and
small clumps were generated by gently pipetting 8x. These cell clumps were cultured in
suspension on ultra-low attachment non-tissue culture treated plates (Corning) for additional 24 h
before transferring into the desired culture system (described below).
Micropatterned EBs
To control aggregate size, a micro-contact printing technique was developed whereby hESC
colonies are cultured on a micro-patterned ECM surface (Peerani, Rao et al. 2007). The microcontact printing process employed a published technique by Tan (Tan, Tien et al. 2002; Tan, Liu
et al. 2004). Briefly, Poly(dimethylsiloxane) (PDMS) circular stamps with diameter, D (400 µm
and 800 µm), and pitch, P (500 µm) were fabricated using standard soft lithography techniques
(Younan Xia 1998). Stamps were inked with an aqueous solution of pH 5 Matrigel™ for 1 h.
After rinsing away excess Matrigel™ and drying stamps with sterile N2, a monolayer of protein
remained on the surface of the stamp. This layer was transferred to a tissue culture treated
substrate (tissue culture dish) after the stamp has been placed in conformal contact with the
substrate for more than 10 sec. The pattern was passivated with 5% w/v Pluronic™-127 (Sigma)
which is used to prevent protein adsorption and cell attachment to unpatterned regions of the
substrate. Matrigel™ patterns were seeded with a single cell suspension of hESCs prepared as
follows: Colonies of hESCs cultured on mEFs were incubated with 0.25% Trypsin-EDTA
(Gibco) for 3 min. Trypsin-EDTA was inactivated with serum-containing hESC differentiation
medium. Vigorous pipetting was used to mechanically dissociate the colonies to single cells.
Cells were centrifuged and then resuspended in serum-free (SF) hESC maintenance medium (XV
medium) consisting of X-Vivo 10 (XV, Biowhittaker), 2mM glutamax, 0.1mM NEAA, 0.1mM
β-mercaptoethanol, 40 ng/mL FGF-2, and 0.1 ng/mL TGF-β. This single cell suspension of
hESCs was plated onto patterns at 1.5 x 106 cells/mL. At 12 h post-seeding, patterned cells were
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washed 3x with XV medium to prevent cell attachment on unpatterned areas. As many as ∼9500
size-controlled aggregates could be generated on a single microscopes slide (9500 EBs/ 9.6cm²).
Patterned colonies were fed daily with 3mL SF-medium until d2 or d3 when the colonies were
transferred to suspension culture to initiate differentiation. To form differentiating aggregates,
d3 patterned hESC colonies were gently scraped off the dishes, and resuspended in hESC
differentiation medium consisting of ko-DMEM, 20% FBS, 2mM glutamax, 0.1mM NEAA,
0.1mM β-mercaptoethanol, 50 IU/mL penicillin and 50 μg/mL streptomycin. These aggregates
were cultured in suspension in the culture systems described below.
Culture systems
Ultra-low attachment plates were used for static culture and small-scale dynamic cultivations on
an orbital shaker (Rotomix VWR, 50 rpm). A Barnstead rotisserie system was employed for
roller-bottle culture (50 mL, 40 rpm). For stirred suspension cultivations, we employed spinner
flasks from a DasGip cellferm-pro bioreactor system provided with a glass bulb impeller (125
mL, 40 rpm) and a plastic paddle equipped Bellco spinner (150 mL, 40 rpm). All bioreactor
cultures were performed with the DasGip cellferm-pro system, a parallel cultivation system that
is capable of monitoring and controlling oxygen tension and pH in up to eight parallel 500-mL
vessels. Cultures were maintained under either normoxic (21% O2 tension) or hypoxic (4% O2
tension) conditions in a medium volume of 125 mL. Medium was replaced every 4 d.
Cell and EB counts
EB numbers and number of contracting EBs were quantified by taking samples of 1mL cell
suspension on d2, d5, d9, d13 and d16 of differentiation. EBs were counted in a 24-well plate
using an inverted-microscope. The same sample was used to determine cell number and viability
by dissociating EBs to single cells followed by trypan-blue staining.
Quantitative RT-PCR
Total RNA was extracted from the cells by homogenization in Trizol (Invitrogen). Extraction
with chloroform was followed by precipitation with iso-propyl alcohol. RNA was purified using
RNAEasy columns (Qiagen) with an on-column DNase-I digestion step. cDNA was generated
from purified RNA with Superscript-III reverse transcriptase (Invitrogen) as per manufacturer’s
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instructions. 10 ng of cDNA was used per PCR reaction with iQ-SYBR-green master mix
(BioRad) in triplicate. Relative expression was determined by delta-delta Ct method with the
expression of α-actin as housekeeping reference. Table 3-I provides a list of all primer
sequences derived from the MGH Primerbank (Wang and Seed 2003). Specificity of
amplification was assured with analysis of dissociation curves of all reactions. Human fetal
heart (FH; BioChain, Total RNA human fetal heart) was used as reference. For all samples a
control was performed without reverse transcriptase and no amplification was detected in these
controls.

Table 3-I – Overview of primer sequences used for quantitative RT-PCR
•

Gene

5’ Primer

3’ Primer

beta-Actin

CATGTACGTTGCTATCCAGGC

Oct4

CTTGAATCCCGAATGGGAAAGGG

Brachyury T

TGCTTCCCTGAGACCCAGTT

Mesp1

CTCTGTTGGAGACCTGGATG

Nkx2.5

GGTGGAGCTGGAGAAGACAGA

FoxC1

ACGGCATCTACCAGTTCATC

Isl1

TGATGAAGCAACTCCAGCAG

Tbx2

ACCCTGAGATGCCCAAAC

GGACTGGCTACCATGCTGTT
CAGTGACGGCGATGAAGT

Tbx5

TACCACCACACCCATCAAC

ACACCAAGACAGGGACAGAC

Mef2c

CGAGATACCCACAACACACG-

TTCGTTCCGGTGATCCTC

α-Actinin

GGGTCCGTTTGCCAGTCAG

GGCTTTCCTTAGGTGGGAGTT

Troponin T

GGACGAAGACGAGCAGGAG

CTTCCGGTGGATGTCATCAAA

MLC2v

TGGGCGAGTGAACGTGAAAAA

CACTTTGAATGCGTTGAGAATGG

CTCCTTAATGTCACGCACGAT
CCTTCCCAAATAGAACCCCCA
GATCACTTCTTTCCTTTGCATCAAG
CCTGCTTGCCTCAAAGTG
CGACGCCGAAGTTCACGAAGT
TCCTTCTCCTCCTTGTCCTT

Immunocytochemistry and confocal laser scanning microscopy
Fluorescence pictures were obtained from d16 cell aggregates after cells were incubated with
Collagenase type IV (2mg/mL, Invitrogen) for 6 min and cell clumps were vigorously pipetted.
Single cells were seeded on fibronectin/gelatin-coated (1 mg fibronectin in 80 mL of 0.02 %
gelatin) 4-well chamber slides (LabTek) at a density of 1 x 104 cells/well. Cells were cultured
for 3 d before staining was performed as previously described (Bauwens, Yin et al. 2005). The
following antibodies were used: α-actinin (EA-53, 1:800, Sigma), sarcomeric actin (A2172,
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1:500, Sigma) and secondary antibodies (Alexa 546 and Alexa 488, both 1:200, Molecular
Probes). Cells were imaged using an Olympus FV1000 confocal laser microscope.
Electrophysiological characterisation
Spontaneous electrical activity of hESC derived cardiomyocytes can be assessed by optical
mapping. D13 EBs were harvested and plated on fibronectin/gelatin-coated culture dishes and
cultured for additional 2 d before analysis. For action potential (AP) tracking, plated EBs were
incubated for 8 min in the dark with 5 µM of di-8-ANNEPS in Tyrode’s salt solution (T2397,
Sigma) followed by three washes with Tyrode solution. Recordings of EBs exhibiting
contracting areas were performed in Tyrode in the dark and at stabilized 37°C. Additionally,
norepinephrine (1 mM, diluted in differentiation medium) was applied during AP tracking.
Experiments were performed using a CMOS optical mapping system with a microscope capable
of magnification and image intensification (Ultima, Brain Vision Inc, Japan). Fluorescence was
excited at 531 nm ± 20 nm with a 150 W halogen light source (MHF-G150LR, Moritek Corp,
Japan,). Emission signal was long pass filtered at 610 nm and recorded for a period of 15s with
temporal resolution as fast as 1 kHz. Changes in dye signal were recorded and analyzed using
BV-analyzer software (Brain Vision Inc, Japan).
Statistics
Values are presented as means ±SD, if not otherwise indicated. Statistical significance was
assessed with one-tailed Student’s t-test at a significance level of 5% and was noted when the pvalue for three independent experiments was less than 0.05. Best-fit regression curves were
assessed for the means of cell numbers and percentage of contracting EBs with polynomial fit
analysis in an order of 2 (fit curve min = 2, fit curve max = 16). All numerical analysis was
performed using Origin 7.5 (OriginLab, Northhampton, MA) graphing and data analysis
software.
RESULTS
Dynamic culture supports cell expansion and yield of contracting EBs
As a first step in developing a bioprocess capable of supporting the production of differentiated
cells from hESCs, we screened a number of dynamic culture systems and compared cell growth
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to static plate controls. Almost no cell expansion was documented for hESCs grown in static
culture after 16d of differentiation (d16 cell-fold expansion 1.0 ± 0.4; Fig. 1A). Switching to
dynamic culture, as reported by others in mESC (Carpenedo, Sargent et al. 2007), resulted in an
improved cell growth, shown here for hESCs cultured in ultra-low attachment dishes on an
orbital shaker table (2.0 ± 0.7). Next we evaluated different scalable culture systems. We found
a cell-fold expansion of 3.8 ± 1.9 in roller bottles, whereas culture in glass-bulb equipped spinner
flasks resulted in an expansion of 5.0 ± 2.8. In spinner systems with a plastic paddle impeller,
cell expansion was found to be 3.8 ± 0.8. These findings suggest that cell growth of
differentiating hESCs is significantly improved by dynamic culture conditions, demonstrated in
four suspension systems differing in agitation forces and vessel geometry. Furthermore, in
comparison to static culture, a higher percentage of EBs with contracting areas was observed in
all dynamic systems tested (Fig. 3.1B). In conclusion a spinner system equipped with a single
glass-bulb impeller (DasGip cellferm-pro spinner flask) was found to be the most favorable for
cell growth and percentage of contracting EBs.
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Figure 3.1: Dynamic culture supports cell expansion and increases percentage of contracting EBs. A: Cellfold expansion of H9 hESCs on d16 of differentiation. By comparing static culture with dynamic culture an
improved cell growth was found in all dynamic systems tested. Ultra-low attachment dishes were used for static
culture and as well for dynamic cultivations on an orbital shaker. A Barnstead rotisserie system was employed for
rollerbottle culture. Stirred suspension cultivations were performed in a DasGip cell-ferm pro spinner system
equipped with a glass bulb impeller and in a Bellco spinner equipped with a plastic paddle impeller. B: Percentage
of EBs with contracting areas. In comparison to static culture on 16d higher percentage of EBs with contracting
areas was observed in all dynamic systems tested. Data are reported as mean with standard deviation of two
independent experiments.
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Robust generation of size-controlled EBs
Creating EBs with conventionally used protocols results in heterogeneous size distributions
(Ungrin, Joshi et al. 2008), which may influence cell fate. Typically, both a wide range of EB
sizes, and significant variations in mean EB sizes between separate runs, are observed. In order
to control input cell population properties, we have developed a robust micropatterning
technique, whereby hESCs were cultured on circular-features varying in diameters (Peerani, Rao
et al. 2007). This technology was adapted to the generation of size-specific aggregates by adding
a colony removal step (Fig. 3.2). Pattern sizes of 400 and 800 µm diameters were chosen based
on earlier results suggesting that small patterns (≤ 200 µm result in predominantly primitive
endoderm differentiation (Peerani, Rao et al. 2007), while large patterns (≥ 800 µm), and thus
large aggregates of cells, may exhibit limited growth and proliferation (Dang, Gerecht-Nir et al.
2004). Two-to-four days after hESCs were printed on MatrigelTM-coated circular patterns, cells
were scraped-off. Patterned aggregates were more homogenous in their size distribution and
shape than EBs induced by traditional techniques (Fig. 3.2A). Noteworthy, on a single
microscope slide as many as ∼9500 size-controlled aggregates could be generated, making this
technology amenable to the generation of large numbers of size-controlled aggregates to seed
bioreactors.
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Figure 3.2: Conventional hEB protocols result in heterogeneous aggregates, whereas micropatterned
aggregates are more uniform in size and shape. (A) Undifferentiated H9 hESC cells on mEFs were used to
induce EB formation using a colony scraping-off technique resulting in uncontrolled formed EBs (UCEBs) (i). For
micropatterning (ii), hESCs on mEFs were scraped-off and seeded as single cells on patterned features. To form
differentiating aggregates, d3 patterned hESC colonies were scraped-off the dish followed by inoculation into stirred
suspension cultures (scale bars: 400 µm). (B) Highest cell outputs were achieved with MP400 aggregates. hESC
colonies were patterned with an initial feature diameter of 400 µm and 800 µm (MP400, MP800), respectively,
followed by growth in stirred suspension. Cell growth was compared to growth of EBs generated by scraping-off
(uncontrolled, UCEBs). (C) Cell expansion of cells derived from MP400 and MP800, respectively, normalized to
expansion of UCEBs. (D) EBs with contracting areas were observed in all three conditions. Data are reported from
two independent experiments each performed with UCEBs (black, dash line), MP400 EBs (black, straight line) and
MP800 EBs (grey, straight line). Polynomial regression analysis was used to model best-fit curves.
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Removing heterogeneity and controlling EB size allows for more robust cell
growth in suspension culture
The above results indicated that controlling aggregate size leads to more uniform EB
populations. As a next step, we investigated if the size-specified aggregates could be grown in
scalable suspension systems. Control aggregates, and aggregates formed using micropatterning,
were formed and cultured in differentiation medium for 24 h in low-attachment dishes, and then
inoculated into spinner flasks equipped with a single glass-bulb impeller (125 mL).
Interestingly, although all three aggregate conditions were seeded at the same initial cell density,
dramatic differences were observed in the overall cell output (Fig. 3.2B, C). Specifically, we
found an improved yield of differentiating cells from micro-patterned hESC colonies (MP) as
opposed to uncontrolled EBs (UCEBs); significant differences were also observed as a function
of micro-patterned aggregate diameter [400 µm (MP400) vs. 800 µm (MP800)]. Trend-lines
generated using polynomial regression with related datapoints for two independent experiments
are shown in Figures 3.2B to D and highlight the impact of each culture condition. After 16 days
of differentiation the MP400 culture delivered the highest yield of differentiating cells; for
example, in one representative experiment (Figure 3.2B) cell outputs were MP400: 7.5 x 105 vs.
MP800: 4.5 x 105 vs. UCEBs: 3.1 x 105 cells/mL. In all three culture conditions, cell viability
was consistently >93%. Figure 3.2C demonstrates the significant differences in cell expansion
observed over 3 experiments, with the outputs from the MP400 and MP800 cultures normalized
to the UCEBs cultures. Aggregates derived from MP400 cells were found to expand 2.9x (± 0.7)
more, whereas MP800 derived cells expanded 1.5x (± 0.14) more, compared to UCEBs. Cell
expansion was significantly increased in MP400 aggregates (p= 0.01) as compared to MP800.
Notably, even after 16d in culture, MPEBs are more uniform in size and more compact than
UCEBs, which typically exhibit a necrotic morphology (Suppl. Figure S2-2). EBs with
contracting areas were observed under all three conditions. The highest percentage of
contracting EBs were found in MP400 culture (Fig. 3.2D).
Impact of oxygen on cell expansion
As a next step in the development of this bioprocess we explored conditions that may further
improve the yield of total cells or differentiated target cells in dynamic suspension systems. Our
previous findings with mESCs suggested that oxygen concentration may be used as a parameter

64

to guide cardiomyogenic induction in differentiating ESCs (Bauwens, Yin et al. 2005). In the
studies reported here, we incorporated this parameter into our bioprocess for hESC
differentiation. EB formation was initiated by scraping-off hESCs colonies. After an additional
24h in static culture 40 EBs/mL were seeded into the bioreactor vessel (DasGip system, 125 mL
volume). In order to compare cell densities achieved in the bioreactor system under hypoxic (4%
oxygen tension) and normoxic conditions (21% oxygen tension, Fig. 3.3A) vs. cell densities
obtained under uncontrolled conditions (UC, employing an identical culture vessel), trend lines
for the two independent experiments were determined using polynomial regression. As shown in
Figure 3.3B the highest cell densities and d16 cell-fold expansion were observed under hypoxia.
For instance, in a representative experiment the highest cell density, 7.4 x 105 cells/mL, was
achieved under hypoxic conditions as compared to 5.6 x 105 cells/mL under normoxic
conditions. Cell expansion normalized to cell expansion in uncontrolled conditions (Fig. 3.3C)
confirms the significant beneficial effect of hypoxia on cell growth. On d16 of differentiation
cell-fold expansion was found to be significantly higher under hypoxic as compared to normoxic
conditions (1.75x ± 0.16 vs. 1.4x ± 0.22; (p= 0.04)). EBs with contracting areas were found in
all three cultures (Fig. 3.3D).
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Figure 3.3: Hypoxia culture in a controlled bioreactor supports cell growth. (A) Oxygen tension profiles in
controlled normoxic and hypoxic bioreactor culture. (B) Growth kinetics of H9 EBs under different oxygen
conditions. hEBs generated by colony scraping-off were cultured in a bioreactor system under hypoxic (pO2 = 4%;
HO) and normoxic (pO2 = 21%; NO) conditions, respectively. Growth was compared to EBs cultured in a
comparable culture vessel but under uncontrolled (UC, incubator) oxygen conditions. Highest cell densities were
achieved under hypoxic conditions. (C) Cell expansion normalized to cell growth under uncontrolled conditions
demonstrates beneficial effect of hypoxia on cell growth. (D) EBs with contracting areas were observed in all three
conditions. Data are reported from two independent experiments each performed under uncontrolled conditions
(black, dash line), hypoxic (black, straight line) and normoxic conditions (black, straight line). Polynomial
regression analysis was used to model best-fit curves.

Combining micropatterning, dynamic culture and oxygen regulation results in a
bioprocess with enhanced cell output.
Our results demonstrate that size-specified EB formation, dynamic systems and oxygen tension
all influence cell proliferation and differentiation output. Consequently, as a next step, we
combined these tools to establish an integrated bioprocess. Performing all experiments with both
H9 and HES2 cells allowed us to validate our process strategy with two cell lines. Human ESC
colonies were patterned at an initial diameter of 400 µm followed by culture in either dish or in
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stirred suspension culture under normoxic and hypoxic conditions, respectively. EBs
conventionally generated with the scraping-off protocol and cultured in uncontrolled conditions
(UC, incubator) served as controls. Raw data are displayed in Figure 3.4 along with best-fit
curves, which were assessed for each condition in order to highlight trends. In dish culture, cell
growth kinetics for both H9 and HES2 cells demonstrate an improved cell growth for
micropatterned EBs cultured under hypoxic conditions as opposed to uncontrolled conditions
(Fig. 3.4Ai). A similar trend was found in stirred suspension culture (Fig. 3.4Aii). For instance
highest cell yields were observed for size-controlled H9 EBs in low oxygen environment
resulting in 5.2 x 105 ± 2.8 x 104 cells/mL (HO) as opposed to 4.0 x 105 ± 2.3 x 104 cells/mL
(NO) vs. 2.2 x 105 ± 8.5 x 104 cells/mL (UC). Table 3-II provides a summary of final cell
numbers with related standard deviations and significance levels generated in all three conditions
highlighting the significant improvement in cell expansion achieved with the novel approach.
Data for cell expansion normalized to uncontrolled conditions support those findings as shown in
Figure 3.4Bi and 3.4Bii. Importantly, although H9-culture resulted in higher overall cell
expansion, similar growth kinetic trends were monitored for both H9 and HES2 cell cultures.
High viabilities were consistently observed in all conditions, such that in a working volume of
125 mL, outputs of e.g. 6.1 x 107 (H9, hypoxic) vs. 5.2 x 107 (H9, normoxic) cells were enabled.
The impact of the new protocol on cell output is summarized in Figure 3.4Ci by comparing stateof-the-art dish cultures to our approach. Notably the novel strategy led to a 5.2 (± 0.26; H9)-fold
cell expansion as opposed to 1.5 (± 0.08)-fold in uncontrolled dish culture translating to a 3.5x
improved cell yield. Contracting areas were observed under all conditions and reflect cardiac
differentiation within the EBs. A significant increase of EBs exhibiting contracting areas was
observed in size-controlled EBs in hypoxic culture as opposed to conventional dish culture,
resulting in 48.8% ± 2.8 vs. 19.0% ± 2.3 contracting EBs (Fig. 3.4Cii). Table 3-II summarizes
data for percentage of contracting EBs in all three conditions. Significance levels highlight the
beneficial effect of controlled over uncontrolled conditions.
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Figure 3.4: Combination of micro-patterning technique and bioreactor regulated environment enhances cell
yield. Micropatterned aggregates (MP) of an initial size of 400 µm were grown under oxygen-controlled conditions
(normoxic (NO); blue symbols and hypoxic (HO); red symbols). Uncontrolled-formed EBs cultured in uncontrolled
oxygen conditions (UC, black symbols) served as internal controls. Each experiment was performed with H9 cells
(straight lines) and HES2 cells (dash lines) for 16 days in dish and spinner culture. (A) Under hypoxic conditions
cell growth was improved in both dish (i) and spinner culture (ii). (B) Normalized cell expansion demonstrates
beneficial effect of hypoxia on cell growth in dish (i) and spinner culture (ii). Statistical significance at the p<0.05
level in comparison to control conditions (UC) is denoted by *. (C) Normalized cell expansion (i) for d16 of
differentiation highlights advantage of size- and oxygen-control on cell expansion by comparing the optimized
approach to state-of-the-art culture. Statistical significance at the p<0.05 level in comparison to control conditions
(UC) is denoted by *. Percentages of contracting EBs grown in common dish culture vs. new protocol (ii). (D)
Percentage of aggregates exhibiting contracting areas during dish (i) and spinner culture (ii). All data are reported
from three independent experiments each performed under uncontrolled, hypoxic and normoxic conditions.
Polynomial regression analysis was used to assess best-fit curves.
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Dish

Table 3-II

UC

HO

Spinner
NO

UC

HO

Cell density d16 [cells/ mL]
H9

1.7x10 ± 1.5x10

HES2

1.5x10 ± 1.0x10

5

5

4

2.3x10 ± 1.5x10 *

2.2x10 ± 8.5x10

4

4.0x10 ± 2.3 x 10

2.2x10 ± 5.0x10 *

3.1x10 ± 3.2x10

4

4.3x10 ± 2.0x10 *

5

4

5

4

3

5

5

5

5

4

4

5.2x10 ± 2.8x10 * **
5

4

6.3 x10 ± 5.0x10 * **
5

4

Contracting EBs d16 [%]
H9

19.0 ± 2.3

20.6 ± 7.7

23.7 ± 3.7

48.3 ± 4.4 *

48.8 ± 2.8 *

HES2

17.5 ± 6.0

23.5 ± 8.0

25.3 ± 1.8

46.1 ± 9.7 *

50.5 ± 12.1 *

Table 3-II - Final cell densities (d16) and percentage of contracting EBs generated in uncontrolled and
controlled conditions. Micropatterned EBs were cultured in dish and spinner culture under hypoxic (HO) and
normoxic (NO) conditions compared to uncontrolled formed EBs cultured in an uncontrolled environment (UC,
incubator). Numbers represent mean ± standard deviation from three independent experiments. Statistical
significance at the p<0.05 level in comparison to control conditions (UC) is denoted by *. Statistical significance at
the p<0.05 level in comparison to normoxic conditions (NO) is denoted by**.

Functional and phenotypic analysis of mesoderm and cardiac development on
cells produced using the integrated bioprocess.
•

Hypoxia enhances cardiac-enriched genes

As a next step we examined the differentiation program induced by hypoxic and normoxic
conditions. Quantitative RT-PCR (qRT-PCR) was carried out on total RNA from differentiated
cells generated in bioreactor cultures under hypoxic and normoxic conditions. Differences were
determined in comparison to pooled RNA from human fetal heart tissue (FH), except for Oct4
expression, which was normalized to RNA from hESCs. RNA was analysed from H9 and HES2
experiments.
Oct4 analysis demonstrated that the initial ESC population differentiated in response to the
inductive conditions employed (Fig. 3.5, Ai). QRT-PCR analyses for several mesodermal and
cardiac markers were then performed. Our analysis revealed a temporal induction of
differentiation, as expected, from mesendoderm and mesoderm markers to more definitive
cardiac-associated genes. Mean expression of brachyury (T) increased in 4d EBs and was found
to be significantly higher (4.4x; H9) under hypoxic conditions as compared to normoxic
conditions, suggesting a supportive effect of low oxygen on mesendoderm differentiation (Fig.
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3.5, Aii). Mesodermal markers Nkx2.5 and transcription factor Mesp1 were highly expressed on
d4 of differentiation in all three conditions (Fig. 3.5, Aiii, Aiv). Brachyury and Mesp1 expression
was found to be increased in hypoxia. Interestingly FOXC1 expression was upregulated on both
d4 and d14 suggesting a role in early and late development as reported before (Beqqali, Kloots et
al. 2006) (Fig. 3.5, Av). LIM domain homeobox gene Isl-1 (ISL1), which has been described as
a marker for a cardiac progenitor cell population (Laugwitz, Moretti et al. 2005), was highly
expressed under hypoxia on 4d, (Fig. 3.5, Avi). After 14d of differentiation up regulation of
cardiac transcription factors T-box (Tbx)2, Tbx5 and Mef2c (Fig. 3.5, Avii, Aviii, Axi) was
detected. Similarly known cardiac genes such as α-Actinin, Troponin T and Myosin light chain
2v (MLC2v; Fig. 3.5, Ax, Axi, Axii) were highly expressed on d14. Gene upregulation of
cardiogenic markers was clearly effected by oxygen tension, e.g. Troponin T and α-Actinin
expression was found to be significantly higher as compared to normoxic conditions: 3.2x (αActinin), 1.7x (Troponin T).
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Figure 3.5: Micropatterned and oxygen controlled bioprocess-generated aggregates exhibit mesodermal and
cardiac-related genes in an oxygen sensitive manner. Quantitative RT-PCR analysis of patterned H9 (filled
columns) and HES2 (sparse columns) aggregates cultured under hypoxic (HO) and normoxic (NO) conditions,
respectively. Conventionally formed EBs in uncontrolled spinner culture (UC) served as internal control. Expression
was normalized to RNA from fetal heart tissue (FH), except Oct4 expression was normalized to RNA from hESCs.
RNA was harvested from the initial ESC population and at d4 and d14 of differentiation. Data are reported from
two independent experiments analysed in duplicates for each data point.

•

Bioprocess generated EBs exhibit cardiac specific morphology and
functionality

Immunocytochemistry was used to characterize cardiac cells. Aggregates were dissociated on
16d of differentiation and replated at a density enabling analysis of individual cells. On average
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three to five percent of the seeded cells demonstrated a typical cardiac morphology with
organized sarcomeric-actin and α-actinin structures (Fig. 3.6A).
In addition, analysis of the replated EBs was performed to explore the function and maturation
stage of the bioprocess generated cells. Cells displaying prolonged action potentials may
represent Purkinje-like cells or cells with primitive levels of expression of ion channels that
regulate repolarisation (Vassalle, Bocchi et al. 2007). Our survey of the upstrokes of the
recorded action potentials revealed that each cell analyzed appeared unique in its
electrophysiological properties. This could suggest that cells of different conduction-system
lineages (nodal vs. ventricular vs. atrial) were generated, or that cells varied between primitive
and mature expression levels of sodium channels (Fig. 3.6B), although the number of beating
areas analyzed (n= 15) is insufficient to make definitive conclusions at this time. To further
assess physiological properties of these cardiomyocytes, we tested whether they could respond to
the adrenergic stimulant norepinephrine (NE). As expected an increased rate of spontaneous
depolarization, and a shortening of action potential duration was observed with NE infusion,
suggesting intact physiological responses in these cells (Fig. 3.6C). In summary, these results
suggest the generation of bona fide cardiomyocytes in our bioreactor process.
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Figure 3.6: Immunohistochemistry and optical mapping studies demonstrate cardiac morphology and
functionality generated from micropatterned aggregates in bioreactor culture. (A) Fluorescence labelling of
bioreactor generated cells. d16 embryoid bodies were dissociated to single cells, plated on chamber slides and
cultured for additional 3 days before staining. Cardiomyocytes within the cell population were detected by α-actinin
(i,ii; red) and sarcomeric actin (iii; green). Cells were double labelled for α-actinin (iv; red), sarcomeric actin (v;
green) and merged image (vi). Nuclear staining appears blue (scale bars represent 50 µm). Figure (B) demonstrates
d15 bioreactor produced aggregates are capable of generating spontaneously beating colonies of cells. Optical
mapping reveal cells with varying action potential duration and shape. (C) Effects of norepinephrine on the
physiology of the bioprocess generated aggregates. The two panels show action potentials recorded before (upper
panel) and after (lower panel) administration of norepinephrine. The effect of the drug shows a shortening of the
action potential duration (APD) and a decreased basic cycle length (BCL). APs were monitored over a period of 15s.
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DISCUSSION
Cell replacement therapy, drug discovery and pharmacotoxicology are applications that require
large numbers of pluripotent cell-derived cells. Well characterized cardiomyocytes and their
progenitors would be a valuable resource of pre-clinical transplantation studies and drug
screening and tissue engineering protocols.
Scalable dynamic culture systems, such as spinner flasks, stirred bioreactors and rotary culture
have been used for the generation of differentiated cells from mESCs (Zandstra, Bauwens et al.
2003; Dang, Gerecht-Nir et al. 2004; Bauwens, Yin et al. 2005; Schroeder, Niebruegge et al.
2005; Carpenedo, Sargent et al. 2007; Niebruegge, Nehring et al. 2008). The beneficial effects
of dynamic conditions on cell viability are well described and likely due to decreased events of
EB agglomeration (Dang, Gerecht-Nir et al. 2004), increased circulation of exogenous factors
(nutrients, soluble factors), increased physicochemical homogeneity (oxygen and pH) and,
importantly, the reduction of endogenously produced inhibitory factors (both metabolites and
cytokines) (Gerecht-Nir, Cohen et al. 2004; Schroeder, Niebruegge et al. 2005; Cameron, Hu et
al. 2006; Carpenedo, Sargent et al. 2007; Niebruegge, Nehring et al. 2008). EB agglomeration is
also directly related to initial EB and cell densities. For our bioprocess an inoculum of 40
EBs/mL (~100 000 cells/mL) was chosen based on previously published data for mESCs and
hESCs (Bauwens, Yin et al. 2005; Cameron, Hu et al. 2006). For future studies it is worthy to
further investigate the impact of initial cell density on hESC growth kinetics.
Importantly, although cell viability and differentiation is promoted by implementing mixing in
three-dimensional systems, resulting EBs typically appear inconsistent in shape and size.
Previously published work (Ng, Davis et al. 2005) has demonstrated a significant role of hEB
size on differentiation outcomes, and we have shown that hESC self-renewal and differentiation
is influenced by colony size (Peerani, Rao et al. 2007). Thus the ability to control the size of an
aggregate, in a manner that can be incorporated into a scalable differentiation bioprocess, may
contribute to a more homogeneous and synchronized cell production system. By incorporating
the micropatterning technique into our bioreactor system we overcame two challenges. First,
initial aggregates with more homogenous in shape and size distribution than conventionly
formed EBs. Second, almost no evidence for oversized aggregates was detected during the
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process, a likely consequence of both the serum-free “predifferentiation” EB induction step and
the mixing in the stirred cultures.
Based on our previous findings with mESCs (Bauwens, Yin et al. 2005) we used the bioreactor
system to evaluate the effect of hypoxia on the yield of hESC derivatives. The impact of oxygen
on mesoderm and cardiac differentiation in the bioprocess was screened using quantitative gene
expression analysis. The fact that differentiation was efficiently initiated from micropatterned
aggregates was demonstrated by downregulated expression of self-renewal associated gene Oct4
as the culture progressed, followed by up regulation of several known mesodermal and cardiac
markers (Mummery, Ward-van Oostwaard et al. 2003; Beqqali, Kloots et al. 2006). Hypoxic
exposure resulted in enhanced expression of mesodermal and early cardiac genes such as
brachyury, Mesp1 and Isl1 indicating the impact of hypoxia at early stages of differentiation.
This data suggests that hypoxia may act to provide a mesoderm-inductive signal. Hypoxia was
furthermore observed to significantly increase the expression of late cardiac genes such as αactinin, Tbx2, Tbx5 and Troponin T.
Notably, compared to well-based EB culture approaches, our culture system combining
aggregate size control with low oxygen tension resulted in a 3.5x increased cell output. A
comparison of hypoxic and normoxic conditions in controlled culture demonstrate the benefits of
hypoxic cultures: final cell numbers were significantly increased (Table 3-II).
Protein-based and functional analyses were also performed on bioreactor generated cells.
Immunocytochemistry of dissociated EBs detected expression of typical cardiac morphology
with highly organized α-actinin and sarcomeric actin structures; this analysis indicates that the
suspension bioreactor and microcontact printing steps did not compromise the ability of the
differentiated cells to re-adhere and express mature cardiac markers. Action potentials (APs)
were recorded from plated EBs. This analysis revealed that APs indeed propagate from a central
colony to the rest of the cells, suggesting that some of these cells may be pacemaker in origin.
The drug responsiveness of the bioprocess generated cells also supports the possibility of their
use in drug screening studies.
Importantly, although the reported bioprocess represents a next-generation technology for the
production of pluripotent cell derivatives, further improvements are necessary to increase the
yield of target cells. Under currently serum-induced differentiation conditions only a subset of
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these cells are mesoderm and cardiac cells fated. We previously used genetic selection systems
to enrich for target cells (Zandstra, Bauwens et al. 2003) and, certainly, with appropriately
engineered hESC lines this strategy could work here. Alternately, incorporating the use of
serum-free media and cytokine driven differentiation as demonstrated in recent developments in
ESC differentiation protocols (Li, Powell et al. 2005; McDevitt, Laflamme et al. 2005; Passier,
Oostwaard et al. 2005; Kattman, Huber et al. 2006; Xu, He et al. 2006; Kattman, Adler et al.
2007; Laflamme, Chen et al. 2007; Yang, Soonpaa et al. 2008; Zhang, Li et al. 2008) could
improve the yield of target cells. An important aspect of transferring bioreactor systems to
serum-free cytokine induced systems will be developing new bioengineering strategies to deliver
recombinant molecules in a cost effective manner, and addressing the known (van der Pol and
Tramper 1998) increased sensitivities of cells to shear in serum free systems.
In this paper we have focused on hESCs as a model system, but the described technology is
broadly adaptable to other cell types, including pluripotent lines produced by iPS cells
(Takahashi, Tanabe et al. 2007; Yu, Vodyanik et al. 2007). Overall, this study contributes
towards the goal of generating pluripotent stem cell-derived cells in a scalable manner under
controlled conditions; an important step in the technological and health-related use of these cells.
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Chapter 4
Geometric Control of Cardiomyogenic Induction in Human
Pluripotent Stem Cells

This chapter has been prepared for submission for publication. Co-authors include Mark Ungrin,
Cheryle Seguin, and Peter W. Zandstra. Authorization to reproduce this work has been obtained
from all co-authors.
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ABSTRACT
Rationale: It has been widely observed that aggregate size affects cardiac differentiation
efficiency of human pluripotent stem cells, but the cellular mechanisms underlying
cardiomyogenesis are incompletely understood. Objective: To develop cellular and molecular
mechanisms for the intrinsic control of human tissue development, we evaluated tissue-specific
differentiation as a function of human embryonic stem cell (hESC) aggregate size, and examined
the effect of manipulating expression of SOX7, a transcription factor required for
extraembryonic endoderm (ExE) commitment, on cardiac development. Methods and Results:
HESC aggregates were generated with either 100, 1000, or 4000 cells per aggregate. We
observed that the frequency of endoderm marker (FoxA2 and GATA6) expressing cells
decreased with increasing aggregate size during early differentiation. Cardiogenesis was
maximized in aggregates initiated from 1000 cells, with 49.2% ± 5.8% (45.6-55.9%) of cells
exhibiting a cardiac progenitor phenotype (KDRlow/C-KITneg) on day 5 (D5) and 23.6% ± 5.7%
(17.1-27.7%) expressing cardiac troponin T on D16. A direct relationship between ExE and
cardiac differentiation efficiency was established by forming aggregates with varying ratios of
SOX7-overexpressing or knockdown hESCs to unmanipulated hESCs, wherein cardiomyocyte
frequency (~27%) was maximized in aggregates formed with 10 to 25% SOX7 overexpressing
cells. Conclusions: We demonstrate that cardiac differentiation efficiency is a function of ExE
cell concentration, a parameter that can be directly modulated by controlling hESC aggregate
size. This is the first presentation of a cellular mechanism to describe the effect of aggregate size
on cardiac development, suggesting that a molecular mechanism may be based on endodermsecreted factors.

78

INTRODUCTION
One of the most common techniques to induce human pluripotent stem cell (hPSC)
differentiation is by forming three-dimensional cell aggregates (Doetschman, Eistetter et al.
1985). Within the developing aggregate, pluripotent stem cells differentiate to cell types
belonging to each of the three germ layers (mesoderm, endoderm, and ectoderm) (Thomson,
Itskovitz-Eldor et al. 1998). Differentiating aggregates are thought to mimic the environment of
the peri-implantation embryo where interactions between various cell types facilitate inductive
events. As in the embryo, one of the earliest events during aggregate-based stem cell
differentiation is the organization of the cells into an outer epithelial layer of extraembryonic
endoderm (ExE) cells surrounding an inner core of epiblast-like pluripotent cells (Coucouvanis
and Martin 1995; Keller 1995; Abe, Niwa et al. 1996; Grabel, Becker et al. 1998; Coucouvanis
and Martin 1999; Ungrin, Joshi et al. 2008; Carpenedo, Bratt-Leal et al. 2009). During
embryonic development, precardiac mesoderm is in close contact with endoderm tissue which
has been shown to play an inductive role as evidenced by the generation of beating cardiac tissue
in cocultures of non-cardiogenic embryonic tissue explants and endodermal tissue (Orts Llorca
1963; Jacobson and Duncan 1968; Sugi and Lough 1994; Nascone and Mercola 1995;
Schultheiss, Xydas et al. 1995). In differentiating PSCs, ExE and its derivatives, visceral and
parietal endoderm, have also been shown to promote cardiomyocyte differentiation in co-culture
and conditioned medium studies (Hogan, Taylor et al. 1981; Bader, Gruss et al. 2001;
Mummery, Ward-van Oostwaard et al. 2003; Passier and Mummery 2005; Passier, Oostwaard et
al. 2005; Bin, Sheng et al. 2006; Xu, Graichen et al. 2008).
One of the main challenges of aggregate-based hPSC differentiation is that heterogeneity and
spatial disorganization leads to inefficient differentiation to specific cell types and a poor
understanding of the mechanisms involved in lineage commitment. In studies addressing this
challenge, two strategies have emerged. One involves exogenously controlling differentiation by
delivering factors that are known or thought to be involved in specification, commitment and
proliferation of the cell type of interest (Laflamme, Chen et al. 2007; Pick, Azzola et al. 2007;
Yang, Soonpaa et al. 2008; Nakanishi, Kurisaki et al. 2009). The second strategy focuses on
controlling physical parameters of aggregate formation, such as aggregate size and shape (Ng,
Davis et al. 2005; Khademhosseini, Ferreira et al. 2006; Mohr, de Pablo et al. 2006; Burridge,
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Anderson et al. 2007; Pick, Azzola et al. 2007; Bauwens, Peerani et al. 2008; Ungrin, Joshi et al.
2008; Niebruegge, Bauwens et al. 2009). We and others have previously reported the
observation that human embryonic stem cell (hESC) aggregate size can be modulated to
optimize cardiac induction efficiency (Burridge, Anderson et al. 2007; Bauwens, Peerani et al.
2008; Hwang, Chung et al. 2009; Mohr, Zhang et al. 2009; Niebruegge, Bauwens et al. 2009),
however the cellular mechanism by which aggregate size and geometry impacts differentiation to
specific cell types remains unclear. Given that the surface area to volume ratio of a sphere
decreases with increasing sphere size, and that an ExE layer forms on the surface of the
differentiating aggregate, we examined the possibility that this geometric relationship dictates
ExE cellularity during early aggregate-based hESC differentiation and the implications of
varying ExE concentration on cardiomyocyte differentiation efficiency.
One challenge in controlling hESC aggregate size has been that hESCs exhibit poor tolerance to
single cell dissociation (Reubinoff, Pera et al. 2000; Burridge, Anderson et al. 2007). A number
of techniques have been developed to address this challenge including forced aggregation of
defined cell numbers (Ng, Davis et al. 2005; Burridge, Anderson et al. 2007; Ungrin, Joshi et al.
2008), or culturing hESCs in maintenance conditions as size specified colonies on
micropatterned extracellular matrix (Bauwens, Peerani et al. 2008; Niebruegge, Bauwens et al.
2009) or as 3-D clumps in size-specified microwells (Khademhosseini, Ferreira et al. 2006;
Mohr, de Pablo et al. 2006; Hwang, Chung et al. 2009; Mohr, Zhang et al. 2009) and then
transferring these colonies or cell clumps to suspension in differentiation medium to induce
aggregate differentiation. Since we previously observed that the status of the input population is
a function of hESC colony size and significantly affects cardiac induction efficiency (Bauwens,
Peerani et al. 2008), we tracked ExE and cardiac development in size specified aggregates
formed using forced aggregation of a single cell suspension (Ungrin, Joshi et al. 2008) to
eliminate heterogeneity of the input hESCs. To investigate the effect of ExE differentiation
frequency on cardiomyocyte differentiation independently of aggregate size, we manipulated the
expression of SOX7. SOX7 is a transcription factor that plays a crucial role in ExE
development. SOX7 silencing leads to inhibition of ExE differentiation of pluripotent cells
(Futaki, Hayashi et al. 2004) and SOX7 overexpression of hESCs leads to the development of an
ExE progenitor phenotype (Seguin, Draper et al. 2008). It should be noted that this is the first
report examining the effect of hESC aggregate size on cardiomyocyte differentiation under
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defined conditions that promote cardiogenesis (Yang, Soonpaa et al. 2008). From the results
presented here, we propose that varying hESC aggregate size leads to geometrically determined
effects on the level of ExE development during early differentiation which subsequently impacts
cardiac differentiation efficiency.
MATERIALS AND METHODS
Cell culture
The H9 (Israel Institute of Technology, WiCell Research Institute), HES2 (ES Cell
International), and CA1 (Nagy Lab, Mount Sinai Hospital, University of Toronto) hESC cell
lines used in these experiments were maintained and expanded as previously described
(Bauwens, Peerani et al. 2008; Seguin, Draper et al. 2008; Yang, Soonpaa et al. 2008). Briefly,
hESC colonies were maintained on mitotically inactivated mouse embryonic fibroblast (MEF)
feeders in Dulbecco’s Modified Eagle Medium: Nutrient Mixture F-12 (DMEM/F12, Invitrogen)
supplemented with 10 to 20% KnockoutTM Serum Replacement (ko-SR, Invitrogen) and 20
ng/mL Basic Fibroblast Growth Factor (FGF-2, Peprotech). Cells were passaged by enzymatic
dissociation. H9 passaging was performed every 4 days by dissociating the cells into small
clumps using Collagenase type IV (2 mg/mL, Invitrogen), whereas CA1 and HES2 cells were
passaged every 7 days by dissociating to single cells using TrypLETM (Invitrogen). SOX7 O/E
cell lines were generated from CA1 cells as previously described (Seguin, Draper et al. 2008)
and maintained in the same conditions as their parental CA1 cell line. Aggregate-based
differentiation of hESCs was carried out using a protocol for serum-free directed differentiation
to the cardiac lineage which has been previously described (Yang, Soonpaa et al. 2008). Briefly,
hESC aggregates were cultured in base media composed of StemPro34 (Invitrogen) with 2 mM
glutamine, 4×10-4 M monothioglycerol (MTG), 50 μg/ml ascorbic acid (Sigma), and 0.5 ng/ml
BMP4. The following concentrations of factors were used for primitive-streak formation and for
mesoderm induction and cardiac specification: BMP4, 10 ng/ml; human bFGF, 5 ng/ml; activin
A, 3 ng/ml; human DKK1, 150 ng/ml; and human VEGF, 10 ng/ml. The factors were added
with the following sequence: days 1–4, BMP4, bFGF and activin A; days 4–8, VEGF and
DKK1; after day 8, VEGF, DKK1 and bFGF. All factors were purchased from R&D Systems.
Cultures were maintained in a 5% CO2/5% O2/90% N2 environment for the first 12 days and then
transferred to a 5% CO2/air environment. HESC aggregate size was controlled by forced

81

aggregation of defined cell concentrations in AggreWells (Stem Cell Technologies),
poly(dimethylsiloxane) (PDMS) inserts containing a textured surface of micro-wells (Ungrin,
Joshi et al. 2008).
Knockdown of SOX7 gene expression in hESCs by siRNA
The DharmafectTM 1 (Dharmacon) delivery system was used to transfect hESCs with
predesigned siRNA against SOX7 (100nM, SMARTpool, L-019017-01) according to the
manufacturer’s protocol in OptiMEM (Invitrogen) base medium. Control cells were similarly
transfected with non-targeting siRNA (ON-TARGETplus Non-targeting Pool, D-001810-10-20).
Cells were enzymatically dissociated to single cells with TrypLE, and seeded onto a Matrigelcoated surface in hESC maintenance medium plus the transfection medium. After 24 hours the
cells were washed and re-fed with hESC maintenance medium alone. 48 hours following
seeding, aggregates were formed by forced aggregation of varying ratios of SOX7 siRNA
transfected HES2 cells and SOX7 O/E CA1 cells (hESC-derived ExE progenitors).
Flow cytometry
HESC colonies or aggregates were dissociated to single cells using the appropriate dissociation
technique. For detection of intracellular proteins FoxA2 (R&D Systems), GATA6 (R&D
Systems), and cardiac troponin T (cTnT, Lab Vision), cells were fixed and permeabilized with
the IntraPrep fixation and permeabilization kit (Immunotech), then incubated in the presence of
primary antibody (1:500 for FoxA2, 1:10 for GATA6, and 1:100 for cTnT) for 20 minutes at
room temperature, followed by an incubation with secondary fluorophore-conjugated antibody
(Molecular Probes) at a 1:100 dilution for 20 minutes at room temperature. For detecting the
expression of surface proteins KDR and C-KIT, live cells were incubated on ice for 30 minutes
in the presence of anti-KDR-PE (Phyco-erythrin; 1:10, R&D Systems) and anti-C-KIT-APC
(Allophycocyanin; 1:100, R&D Systems). Cells were analyzed using a FACSCanto (BD
Biosciences) flow cytometer. Positive staining was defined as the emission of a level of
fluorescence that exceeded levels obtained by 99.5% of cells from the control population stained
with only the secondary antibody.
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Confocal microscopy
HESC aggregates were fixed and stained for confocal microscopy imaging at different stages in
the differentiation culture using a protocol that has been previously described (Bauwens, Yin et
al. 2005). The following antibodies were used: FoxA2 (1:1000), and secondary antibodies
(1:200, Molecular Probes). Cell nuclei were detected by staining aggregates with Hoechst 33342
(Molecular Probes). Cells were imaged at the University Health Network’s Advanced Optical
Microscopy Facility using an Olympus FV1000 confocal laser microscope.
Immunostaining and Imaging
Fluorescent images of Sox7 (1:100, R&D Systems), Sox17 (1:100, R&D Systems), and GATA-6
(1:20, R&D Systems) protein expression were obtained with the Cellomics Arrayscan VTI
platform and quantitatively analyzed using the Target Activation assay algorithms available with
the Cellomics Arrayscan VTI platform (Cellomics).
Statistics
All data shown are the mean of three independent experiments with error bars on plots
representing the standard deviation of the mean unless otherwise indicated. To evaluate
differences between conditions, statistics were computed in Origin 7.5 using the the two sample
t-test or one-way ANOVA as indicated at a significance level of P < 0.5.
RESULTS
Establishing optimal hESC aggregate size to maximize cardiomyocyte
differentiation
Cardiac induction and differentiation was assessed in hESC aggregates formed with 100, 1000
and 4000 cells per aggregate (Figure 4.1A). It was previously reported that when conventional
scraped EBs, cultured in the same defined conditions used for the studies presented here, were
analyzed for expression of KDR and CKIT on day (D)5/6, three distinct populations emerged:
KDRhigh/CKITpos, KDRlow/CKITneg, and KDRneg/CKITpos (Yang, Soonpaa et al. 2008). In that
report it was demonstrated that the KDRlow/CKITpos population expressed high levels of genes
involved in cardiac development and that these cells subsequently gave rise to an enriched
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population of cells expressing mature cardiac differentiation markers (Yang, Soonpaa et al.
2008). We therefore assayed the same markers to assess the influence of aggregate size on
cardiac induction. Representative flow cytometry dot plots are presented in Figure 4.1B. The
results of the KDR/CKIT flow cytometry analysis demonstrate that the large (4000 cells) and
small (100 cells) aggregate sizes we tested were not optimal for cardiac induction, and that the
highest frequency of KDRlow/CKITneg cells were detected in the mid- size condition (1000 cells)
(Figure 4.1C). This observation is consistent with previously published findings that varying
aggregate size modulates the level of cardiac induction during hESC differentiation (Burridge,
Anderson et al. 2007; Bauwens, Peerani et al. 2008; Hwang, Chung et al. 2009; Mohr, Zhang et
al. 2009).
By day 12 of differentiation, spontaneous contractions were observed in the majority of EBs
under all size conditions. Mature cardiac differentiation was assessed by measuring the
frequency of cardiac troponin T (cTnT) expressing cells in D16 size-specified aggregates using
flow cytometry (representative flow cytometry histograms are presented in Figure 4.1D).
Corresponding to the results of the cardiac induction analysis, the highest percentage
(approximately 25%) of cTnT expressing cells was detected in aggregates initiated with 1000
cells (Figure 4.1E). Aggregates formed with 100 and 4000 cells exhibited lower frequencies of
cTnT expression by D16, ranging between 5 to 10% (Figure 4.1E). This data demonstrates that
controlling aggregate size with respect to the number of cells per aggregate influences cardiac
induction and differentiation even in defined medium that contains factors that specify cardiac
commitment and expansion.

84

Figure 4.1: Of the three EB sizes investigated, cardiac induction is maximized in EBs generated from 1000
cells. (A) Phase contrast microscopy images of size controlled aggregates initiated with 100, 1000, or 4000 cells
per aggregate. (B) Representative flow cytometry dot plots for the cardiac progenitor analysis examining KDR and
C-KIT protein expression. The population identified as not expressing C-KIT and expressing KDR protein at low
levels is recognized as a cardiac progenitor enriched population. (C) Bar graph displaying the frequency of
KDRlow/C-KIT- cells in D5 size-controlled EBs. * indicates significantly different values as determined by a two
sample t-test. (D) Representative flow cytometry histograms for the expression of cardiac marker cTnT in d16 sizecontrolled EBs. (E) Bar graph displaying the frequency cTnT+ cells in D16 size-controlled EBs. * indicates
significantly different values as determined by a two sample t-test.

Emergence and spatial organization of endoderm cells in size-controlled
aggregates
We next evaluated spatial organization in differentiating hESC aggregates to confirm that
endoderm cells develop on the surface of the spheroid during early differentiation. Figure 4.2A
outlines the relationship between the surface area and volume of a sphere as sphere radius
doubles. With each radius doubling, the surface area to volume ratio of a sphere is halved. If an
inverse relationship also applies to the development of the ExE layer on the surface of a
differentiating hESC aggregate, then ExE frequency during early differentiation decreases with
increasing aggregate size. Confocal imaging revealed the spatial expression of the endoderm
protein marker FoxA2 was mainly localized to the surface of D4 aggregates (Figure 4.2B). This
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analysis suggested that spatial organization of endoderm cells to the aggregate surface occurs in
hESC aggregates formed by forced aggregation in the AggrewellTM system.
The capacity for hESC differentiation along the endoderm lineage increases with
decreasing aggregate size
To directly evaluate the effect of aggregate size on endoderm concentration during early
differentiation, size specified aggregates were assessed at D0, D1, D3, and D6 of differentiation
for frequency of cells expressing the endoderm protein markers FoxA2 and GATA6 by flow
cytometry (Figure 4.2C, D). Figure 4.2C depicts representative dot plots from the flow
cytometry analysis. A trend emerged in which the frequency of FoxA2+ and GATA6+ cells
increased with decreasing aggregate size at each timepoint, with the smallest aggregates that
were formed at an initial size of 100 cells consistently exhibiting the highest frequency of
endoderm marker-expressing cells (Figure 4.2D). Similar protein expression profiles were
observed for both endoderm markers tested at all three aggregate sizes, with maximum
frequencies generally reached by D3 of the timepoints that were analyzed. FoxA2 expression
reached a maximum level of 7.30% ± 1.30% in the smallest aggregate condition (initiated with
100 cells) on D3, whereas the largest aggregates (formed with 4000 cells) consistently displayed
the lowest frequencies of FoxA2+ cells never exceeding 3% (Figure 4.2Di). Maximum
expression frequencies for GATA6 were also observed on D3, where the highest levels of cells
expressing the protein (11.93% ± 1.32% of cells) was observed in the smallest aggregate size
condition (initiated with 100 cells) and the lowest levels (6.40% ± 0.71%) in the largest
aggregates (initiated with 4000 cells) (Figure 4.2Dii).
D3 aggregate diameters were measured by analyzing phase contrast microscope images of the
aggregates and these values were then used to estimate the ratio of the volume of the outer layer
of cells (OV) to the total aggregate volume (TV). To estimate the outer cell layer volume, the
diameter of a single cell was assumed to equal 10 μm(Sharma, Cabana et al. 2008). The OV/TV
ratios for aggregates generated with 100, 1000 and 4000 cells are presented in Figure 4.2E.
Under all aggregate size conditions, the OV/TV ratios decreased with increasing aggregates size
similar to the trend observed in tracking FoxA2+ and GATA6+ cells on D3, and consistent with
our hypothesis. In all cases, the OV/TV ratios were higher than the corresponding FoxA2+ and
GATA6+ cell frequencies (100 cell aggregates: OV/TV ~ 0.6, FoxA2+ ~ 0.07, GATA6+ ~ 0.12;
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1000 cell aggregates: OV/TV ~ 0.3, FoxA2+ ~ 0.05, GATA6+ ~ 0.09; 4000 cell aggregates:
OV/TV ~ 0.2, FoxA2+ ~ 0.03, GATA6+ ~ 0.06), indicating that either endoderm cells do not
make up a complete layer surrounding the aggregate, cells in the outer layer may not be as
densely packed as cells located in the interior of the aggregate, or may vary in size from inner
cells. It can be observed in the confocal images (Figure 4.2B) that not all aggregates contain an
outer layer of endoderm cells and that in many aggregates endoderm cells do not make up the
full layer of outer cells.
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Figure 4.2: Endoderm cells develop on the surface of size-specified hESC aggregates formed by forced
aggregation and endoderm differentiation frequency decreases with increasing hESC aggregate size. (A) An
illustration of the underlying concept behind the hypothesis that the level of extraembryonic endoderm
differentiation is inversely proportional to EB size. (B) Confocal microscopy image of aggregates demonstrating
protein expression of FoxA2 (red, blue = Hoechst nuclear staining) in D4 EBs generated from 1000 cells. Scale bar
= 250 μm. (C) Representative flow cytometry dot plots for FoxA2 and GATA6 protein expression. (D) Kinetics
of the frequency of cells expressing endoderm-associated proteins FoxA2 (i) and GATA6 (ii) in aggregates
generated from 100, 1000, and 4000 cells. * represents significant differences between the values at each time point
as determined by ANOVA analysis. (E) The ratio of the volumes of the outer layer of cells to the total aggregate of
D3 aggregates generated with 100, 1000, and 4000 cells per aggregate, determined by image analysis of phase
contrast microscope images. * indicates significantly different values as determined by a two sample t-test.
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Varying the frequency of ExE progenitor cells in hESC aggregates influences
cardiac differentiation efficiency in size controlled hESC aggregates
independently of aggregate size
As it was observed that cardiac induction and differentiation could be modulated by varying
hESC aggregate size and that there was an inverse relationship between aggregate size and the
frequency of endoderm cells present during the first six days of differentiation, we next
examined the possibility that the frequency of endoderm cells can be optimized to maximize
cardiomyocyte differentiation efficiency. To vary ExE frequency independently from aggregate
size, we manipulated the expression of SOX7, a transcription factor that is required for ExE
differentiation (Futaki, Hayashi et al. 2004; Seguin, Draper et al. 2008), in the input hESC
population (Figure 4.3A). To study the effect of increasing ExE frequency, 1000 cell aggregates
were generated with varying ratios of normal hESCs to SOX7-overexpressing (O/E) hESCs (ExE
progenitors) (Figure 4.3Bi). Conversely, the effect of reducing ExE frequency was examined by
generating 1000 cell aggregates with varying ratios of normal hESCs to knockdown SOX7
hESCs (kd-SOX7) (Figure 4.3Bii). SOX7 expression was induced in genetically engineered
CA1 hESC lines (SOX7 O/E) following transient expression of Cre recombinase. An ExE
progenitor phenotype in transgenic cell lines was confirmed by expression of SOX7, GATA6
and SOX17 proteins, markers that are associated with an ExE phenotype (Supplementary Figure
S3-1). SiRNA transfection was employed to silence SOX7 expression in hESCs. SOX7 siRNA
transfection was validated by demonstrating SOX7 protein knockdown in the SOX7 O/E cells
that were transfected with the siRNA (Supplementary Figure S3-2).
The frequency of cTnT+ cells on D16 was measured to track cardiomyocyte differentiation
frequency with respect to input ExE progenitor (SOX7 O/E hESC) or kd-SOX7 hESC frequency.
Parallel controls that were carried out included the parental non-Cre-transfected CA1 cells in
place of SOX7 O/E hESCs or non-targeting siRNA-transfected hESCs in place of kd-SOX7
hESCs. It was observed that cardiomyocyte differentiation efficiency varied in response to
different input levels of ExE progenitors (Figure 4.3Ci). Maximum cardiac differentiation
(27.55% ± 4.74% and 27.50% ± 1.90%) was observed in aggregates generated with 10% to 25%
SOX7 O/E hESCs (Figure 4.3Ci). In the condition initiated with 50% input ExE progenitors,
cardiomyocyte differentiation efficiency returned to control levels (13.4%). As expected, in
aggregates initiated with 100% ExE progenitors, cardiomyocyte differentiation was drastically
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reduced (3.1%) from control levels. A negative response to increasing frequencies of kd-SOX7
hESCs was observed with respect to cardiomyocyte differentiation efficiency (Figure 4.3Cii),
wherein all aggregates containing kd-SOX7 hESCs exhibited reduced cardiomyocyte frequencies
compared to the control condition reaching a minimum of 2.5% cTnT+ in aggregates generated
with 100% kd-SOX7 hESCs, indicating that although SOX7-expressing cells do not efficiently
differentiate towards the cardiac lineage their presence promotes cardiogenesis. From these
findings it was concluded that by manipulating the input frequencies of ExE progenitors,
cardiomyocyte differentiation could be attenuated or increased even in the presence of growth
factors that specifically direct cardiac commitment and expansion, suggesting that ExE cells
exert a cell non autonomous effect on differentiating hESCs.

Figure 4.3: The frequency of input ExE cells has an aggregate size independent effect on cardiomyocyte
differentiation efficiency. (A) ExE differentiation is blocked by transfecting cells with siRNA that silences SOX7
transcription factor (ko-SOX7) and promoted in genetically engineered cells that over-express SOX7 upon
transfection with Cre (SOX7 O/E). (B) Size controlled EBs are formed at controlled ratios of SOX7 O/E and koSOX7. (C) Frequency of cardiomyocytes (cTnTpos) in D16 EBs generated with varying frequencies of SOX7 O/E
cells or (D) siSOX7-transfected cells (N=2).
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DISCUSSION
Using a variety of methods to control aggregate size, a number of reports have demonstrated that
this parameter influences hPSC differentiation along the cardiac lineage (Burridge, Anderson et
al. 2007; Bauwens, Peerani et al. 2008; Mohr, Zhang et al. 2009; Niebruegge, Bauwens et al.
2009). A significant observation that has been made consistently across these studies is that
there is a specific range of aggregate sizes, usually defined by aggregate diameter, in which the
frequency of contracting aggregates and cardiac-associated gene expression is maximized. In
aggregates generated by either forced aggregation (Burridge, Anderson et al. 2007) or in
microwells (Mohr, Zhang et al. 2009), it has been shown that the frequency of contracting
aggregates and expression of cardiac-associated genes was maximized in aggregates with
diameters in the 250 to 350 μm range, and decreased in smaller and larger aggregates. Even
under conditions in which aggregate size has been optimized however, cardiac differentiation
efficiency appears to be quite low in these studies, with observed frequency of contracting
aggregates typically less than 25% (Burridge, Anderson et al. 2007; Mohr, Zhang et al. 2009),
and in the few cases where cardiomyocyte differentiation frequency was evaluated, less than 5%
of cells expressed cardiac-specific proteins (Bauwens, Peerani et al. 2008; Mohr, Zhang et al.
2009).
The present study is the first report investigating the effect of hESC aggregate size on
cardiomyocyte differentiation under defined conditions that promote cardiogenesis. In addition,
more robust metrics for aggregate size and cardiac differentiation efficiency were employed than
in the previously described reports. Aggregate size was defined in terms of the number of input
cells per aggregate, not aggregate diameter which can represent slightly different cell numbers
between runs depending on cell density. To more accurately determine cardiomyocyte
differentiation efficiency we analyzed the frequency of cells expressing cardiac progenitor and
mature cardiac markers, instead of counting the frequency of beating aggregates or determining
relative gene expression levels of cardiac markers. Similar to previous reports, we observed a
trend wherein cardiomyocyte induction and differentiation was attenuated in aggregates that
were too small or too large even in the presence of growth factors that specify the cardiac
lineage, and mid-size aggregates (initiated with 1000 cells) produced the highest levels of D5
cardiac progenitors (~50%) and D16 cardiomyocytes (~25%). While the trend we observed was
similar to previous studies, under defined conditions that specify cardiac induction we achieved
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significantly higher levels of cardiomyocyte differentiation in hESC size-controlled aggregates
than in any prior reports.
From the findings presented here we propose a cellular mechanism to describe how aggregate
size affects cardiomyocyte differentiation efficiency. We reasoned that aggregate size
determined the level of cardiac-promoting ExE that developed by a simple geometric
relationship; that the ratio of the surface area to volume of a sphere decreased with increasing
sphere diameter. In this case, aggregate size could be varied to directly control the frequency of
ExE differentiation which subsequently could impact the efficiency of cardiac differentiation.
Tracking endoderm frequency over the first 6 days in size-specified aggregates, we observed a
relationship in which the level of endoderm cell development decreased with increasing
aggregate size, supporting the hypothesis that the level of endoderm differentiation is related to
the ratio of outer cells to inner cells in the cell spheroid. A direct relationship between frequency
of ExE cells during aggregate formation and cardiomyocyte differentiation efficiency was
confirmed by monitoring cardiomyocyte frequency in size-specified hESC aggregates that were
generated with controlled frequencies of cells that either overexpressed SOX7 transcription
factor or were transfected with siRNA blocking SOX7 transcription. Our findings support the
concept that there is a geometric relationship between hESC aggregate size and the extent of ExE
development during early differentiation that subsequently impacts cardiac induction and
differentiation efficiency.
It has been suggested that the effect of hESC aggregate size on cardiac differentiation is
influenced by the diffusion of critical substrates and growth factors throughout the aggregate
(Mohr, Zhang et al. 2009). Certainly, during embryogenesis spatial gradients of several
signaling molecules are involved in guiding cardiac development, many originating from ExE
cells as previously described. The inductive characteristic of the endoderm has been attributed to
TGF-β superfamily and FGF family growth factors that have been reported to be involved in
cardiac differentiation (Sugi and Lough 1994; Schultheiss, Xydas et al. 1995; Sugi and Lough
1995; Schultheiss, Burch et al. 1997; Schultheiss and Lassar 1997). It has been shown using
mouse (m)ESCs that inhibition of primitive endoderm with diffusible leukemia inhibitory factor
(LIF) during cell aggregation attenuates cardiomyocyte differentiation and that
cardiomyogenesis could be rescued with parietal endoderm conditioned medium (Bader, Gruss et
al. 2001), suggesting that the primitive endoderm secretes factors that contribute to cardiac
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commitment in a paracrine, LIF independent manner. In mESC aggregates generated by mixing
different ratios of Dox-inducible GATA4 overexpressing mESCs with the untransfected parental
cell line (Holtzinger, Rosenfeld et al. 2010), GATA4 overexpressing cells develop into SOX17+
cells that secrete BMPs and DKK to promote cardiac induction in the non-GATA4
overexpressing cells. It has been recently observed in the mESC system that Wnt5A gene
expression is modulated in an aggregate size dependent manner wherein lower gene expression
in larger aggregates (generated from 450 μm diameter microwells) corresponded to enhanced
cardiogenesis based on frequency of beating aggregates and cardiac gene expression (Hwang,
Chung et al. 2009). In the same study it was shown that GATA4 mRNA was highly expressed in
larger aggregates. It may be that the GATA4-expressing cells secrete enough DKK to inhibit
Wnt5A in the larger aggregate condition. SPARC (Secreted Protein, Acidic, Rich in Cysteine), a
matricellular glycoprotein that is highly expressed in the developing heart (Holland, Harper et al.
1987; Brekken and Sage 2001), is another candidate molecule secreted by parietal endoderm that
has been shown to promote early myocardial differentiation in mESC aggregates (Stary,
Pasteiner et al. 2005; Hrabchak, Ringuette et al. 2008). Mouse ESC aggregates cultured in
parietal endoderm conditioned medium exhibit enhanced cardiac differentiation (Stary, Pasteiner
et al. 2005); an effect which is abrogated with the addition of anti-SPARC antibodies in a
concentration-dependent manner.
In conclusion, we have established a robust system for hESC aggregate-size controlled cardiac
induction and differentiation. Using this system, it was determined that aggregate size influences
endoderm differentiation efficiency, and that the concentration of ExE in size controlled
aggregates directly influences cardiac differentiation efficiency. This system establishes a basis
to examine the effect of endoderm-secreted factors on cardiogenesis in aggregate size-controlled
hPSC aggregates.
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Chapter 5
Discussion and Future Work
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THE MECHANISM UNDERLYING THE EFFECT OF HPSC AGGREGATE SIZE ON
CARDIOMYOGENESIS
As demonstrated here and widely reported by others, aggregate size is a parameter that can be
varied to influence pluripotent stem cell differentiation along the cardiac lineage (Burridge,
Anderson et al. 2007; Bauwens, Peerani et al. 2008; Mohr, Zhang et al. 2009; Niebruegge,
Bauwens et al. 2009). What remained to be determined was the mechanism underlying this
observation. Herein, we have revealed a cellular mechanism to describe how aggregate size
influences cardiac induction by modulating the frequency of cardiac-promoting ExE cells which
form an epithelial layer surrounding the differentiating aggregate. Interestingly, a recent report
has suggested that spatial organization in hESC-derived EBs differs from mESC-derived EBs,
wherein the outer layer is composed of OCT4+ ectoderm, and primitive endoderm cells are
located in the interior of the aggregate based on expression of erythropoietin receptor (EPOR)
(Kopper, Giladi et al. 2010). The authors suggested that the EPOR+ cells may represent
primitive endoderm because this marker is also expressed in the yolk sac of 7 day old embryos.
This report appears to contradict our own observations that ExE cells are located on the
aggregate surface based on the expression of FoxA2 and GATA6 (Ungrin, Joshi et al. 2008). It
has been previously reported that primitive endoderm cells do not originate at the EB surface but
first appear throughout the EB and subsequently migrate to the surface to form an epithelial layer
(Rula, Cai et al. 2007; Moore, Cai et al. 2009). Early aggregates of F9 embryonal carcinoma
cells (1 and 2 days old) are largely made up of undifferentiated cells but do contain a few
primitive endoderm cells, detected by the expression of GATA4 and the cytoplasmic endocytic
adaptor Dab2 (Rula, Cai et al. 2007), which are mainly located in the interior of some of the
spheroids with some also present on the surface. By day 4 and 7 of aggregate culture primitive
endoderm cells are located on the outer layer of the aggregates, probably by migration, and only
a few differentiated cells are located in the interior. Therefore the discrepancy between our
observations and those made by Koppler et al may be attributed to the timing of aggregate
analysis. Koppler et al analyzed 2 and 3 day old EBs, while we only observe a surface layer of
endoderm cells starting at day 4 of aggregate culture (Figure 4.2). Interesting future studies in
our system could include tracking the endoderm population during the course of differentiation
and tracking the SOX7 O/E hESC population in our EB co-cultures.
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An important observation made in these studies is that cell-cell interactions can override
exogenous signals during hESC maintenance and differentiation. The development of protocols
designed to either maintain pluripotent stem cell populations in the undifferentiated state or
differentiate pluripotent stem cells along specific lineages has been largely based on bulk
addition of exogenous factors to the culture medium. In the case of hESC maintenance this
strategy has consisted of culturing colonies in the presence of saturating concentrations of TGF-β
and bFGF. As illustrated in Chapter 2, however, gene expression profiles for hESCs cultured
under these conditions vary widely from run to run and it was observed that cell interactions,
manipulated by controlling colony size, have a tremendous impact on gene and protein
expression status and the subsequent differentiation trajectory of hESCs. These findings, along
with previous work published by our lab (Peerani, Rao et al. 2007), suggest that manipulating the
physical arrangement of cells in these cultures may influence hESC fate despite the addition of
exogenous factors to the medium (Peerani, Rao et al. 2007; Bauwens, Peerani et al. 2008).
Similarly, protocols for hESC differentiation to cardiomyocytes typically rely on exogenous
factors that are either provided by serum (Kehat, Kenyagin-Karsenti et al. 2001; Xu, Police et al.
2002), secretions from an inductive cell type (Mummery, Ward-van Oostwaard et al. 2003;
Passier, Oostwaard et al. 2005), or directly added in a manner meant to mimic the timing and
secretion of growth factors during gastrulation in the embryo (Yang, Soonpaa et al. 2008). It
was demonstrated in Chapters 2 through 4 that cardiac differentiation efficiency in hEBs cultured
in the presence of exogenous factors that specify the cardiac lineage could be further influenced
by manipulating aggregate size. Indeed, examining the frequency of cardiomyocytes produced
in aggregates generated from 100, 1000, and 4000 cells per aggregate, it appears that in small
and large aggregates, cardiac induction is hindered despite the presence of growth factors that are
supposed to promote cardiac specification and commitment.
We have collected data that describes a cellular mechanism behind the effect of hESC aggregate
size on cardiomyogenesis, however the molecular basis for the effect of aggregate size on
cardiogenesis has still not been explored. Now that it has been established that endoderm
differentiation can be regulated by manipulating aggregate size and that ExE frequency directly
affects cardiac differentiation efficiency, future studies can focus on examining the role of
factors secreted by SOX7 O/E hESCs on cardiac development. There are a number of candidate
cardiogenic molecules originating from extraembryonic endoderm cells. One of the only
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published studies examining the underlying biology behind the effect of (mESC) aggregate size
on cardiac induction demonstrated that Wnt11 expression along with lower levels of Wnt5A
gene expression in larger EBs (generated from 450 μm diameter microwells) corresponded with
enhanced cardiogenesis based on frequency of beating EBs and cardiac gene expression (Hwang,
Chung et al. 2009). In the same study it was shown that GATA4 mRNA was highly expressed in
larger EBs. GATA4-expressing endoderm cells have been shown to secrete DKK, a Wnt
inhibitor (Holtzinger, Rosenfeld et al. 2010). SPARC (Secreted Protein, Acidic, Rich in
Cysteine) is another candidate molecule secreted by parietal endoderm that has been shown to
promote early myocardial differentiation in mouse EBs (Stary, Pasteiner et al. 2005; Hrabchak,
Ringuette et al. 2008). SPARC is a matricellular glycoprotein that is highly expressed in the
developing heart (Holland, Harper et al. 1987; Brekken and Sage 2001). Mouse EBs cultured in
parietal endoderm conditioned medium exhibit enhanced cardiac differentiation (Stary, Pasteiner
et al. 2005); an effect which is abrogated with the addition of anti-SPARC antibodies in a
concentration-dependent manner. Additionally TGF- and FGF-family proteins are known to
promote PS formation and exogenously added to hESC differentiation cultures to direct cardiac
development (Kattman, Adler et al. 2007; Laflamme, Chen et al. 2007; Yang, Soonpaa et al.
2008).
A direct link between SOX7 expression and cardiogenesis has been previously examined
(Nelson, Chiriac et al. 2009). SOX family transcription factors have been implicated in the
regulation of cardiac and/or vascular fate selection during early embryonic development (Naito,
Shiojima et al. 2006; Nelson, Chiriac et al. 2009). Bioinformatics analysis has revealed that the
Wnt/β-catenin signaling pathway, which has been demonstrated to drive early progenitor cells
into mature cardiomyocytes, is a target of SOX transcription factors (Faustino, Behfar et al.
2008). Differential SOX7 expression has been associated with cardiovascular lineage
specification in Flk-1+ PS-like cells (Nelson, Chiriac et al. 2009). It has also been reported that
SOX7 can inhibit the Wnt/β-catenin pathway (Takash, Canizares et al. 2001), which as discussed
in Chapter 1, is involved in commitment of mesoderm towards the vascular and hematopoietic
lineages but inhibits cardiac induction (Naito, Shiojima et al. 2006). Therefore, investigating
downstream SOX7 signalling may also provide insights into the molecular mechanism behind
the role of ExE in promotoing cardiogenesis.
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DEFINITIVE ENDODERM (DE) VERSUS EXE: PROMOTING SPECIFIC CARDIAC
CELL TYPES
In Chapter 4, the investigation into the effect of aggregate size on endoderm differentiation
showed that the frequency of cells expressing the pan-endodermal markers FoxA2 and GATA6
decreased with increasing aggregate size during the first 6 days of differentiation. The
subsequent analysis assaying the effect of SOX7 O/E hESC frequency on cardiac differentiation
indicated that ExE cells specifically promote cardiogenesis but did not eliminate the possibility
that definitive endoderm (DE) cells also contribute to the aggregate size effect observed.
Reports specifically examining the effect of DE on cardiac development have been sparse and
contradictory. In zebrafish, although heart morphogenesis is severely disrupted when endoderm
formation is impaired following inactivation of a Sox-related transcription factor (Kikuchi,
Agathon et al. 2001) cardiac tissue still forms (Alexander, Rothenberg et al. 1999; Latinkic,
Kotecha et al. 2003). Therefore it appears that induction of cardiac tissue can occur in the
absence of endoderm. In xenopus, ectopic expression of GATA4 in animal pole explants results
in the formation of DE tissues such as gut (Weber, Symes et al. 2000) and liver. However, it was
observed that GATA4-mediated cardiac induction was not dependent on the presence of
endoderm in these explants. In fact inhibition of endoderm differentiation by a dominantnegative form of the endoderm transcription factor SOX17β actually led to increased formation
of cardiac tissue (Latinkic, Kotecha et al. 2003). These findings appear to suggest that in
xenopus the formation of DE may in fact antagonize cardiogenesis, or that inhibition of SOX17
expression may shift cell fate from endoderm to mesoderm (Clements and Woodland 2000).
Reports on the role of SOX17 on cardiac mesoderm specification in mESCs appear to contradict
what has been observed in xenopus (Liu, Asakura et al. 2007). RNA interference of SOX17
using short hairpin RNA (shRNA) did not impair mesendoderm formation but suppressed Mesp1
and Mesp2 transcription factors that are required for cardiac induction (Kitajima, Takagi et al.
2000). Suppression of SOX17 by either shRNA or treatment with Noggin and sFz8 was
followed by suppression of transcription factors for endoderm (FoxA1 and FoxA2) and cardiac
differentiation (Nkx2.5, Tbx5, Mef2c, and Myocd). Further indications of impaired cardiac
differentiation in mESC-derived EBs were the lack of sarcomeric proteins and spontaneous
contractions as cultures progressed. Inhibition of SOX17 did not appear to impair mesendoderm
formation, as Oct4 pluripotency marker was downregulated upon initiating differentiation and PS
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markers, brachyury and Gsc, as well as hematopoietic marker Runx1 were upregulated. Flk1, a
mesoderm marker expressed by both hematopoietic and cardiac muscle progenitors, expression
was impaired in 4 to 5 day old EBs however (Liu, Asakura et al. 2007). In mouse EBs generated
by mixing different ratios of Dox-inducible GATA4 overexpressing mESCs with the
untransfected parental cell line (Holtzinger, Rosenfeld et al. 2010), GATA4 overexpressing cells
develop into SOX17+ cells that secrete BMPs and DKK to promote cardiac induction in the nonGATA4 overexpressing cells.
From the conflicting results of these studies, the effect of DE on cardiac specification during
embryogenesis is still unclear. It was suggested that impaired cardiac development upon
inhibiting SOX17 in mESCs occurred because SOX proteins interfere with canonical Wnt
signaling while expression of cardiogenic Wnt11 was impaired following suppression of SOX17
(Liu, Asakura et al. 2007). It should also be noted that SOX17 expression is not exclusive to DE,
but is also expressed by ExE during embryogenesis (Hudson, Clements et al. 1997; KanaiAzuma, Kanai et al. 2002). Previous reports suggest that Sox17 contributes to later
differentiation of the visceral and parietal endoderm (Shimoda, Kanai-Azuma et al. 2007).
Therefore, in these studies it may still be unclear whether it is the lack of DE or ExE that is
affecting cardiogenesis.
Using the system developed herein, it would be relatively simple to test the effect of DE on
cardiac induction and differentiation. Similar to the SOX7 O/E hESC cell lines used here in the
studies presented in Chapter 4, hESCs have also been genetically engineered to overexpress
SOX17 in CA1 and CA2 cell lines (Seguin, Draper et al. 2008). SOX17 O/E hESCs were
analyzed after being exposed to either BMP, which is used to induce ExE and trophectoderm
differentiation from hESCs (Xu, Chen et al. 2002; Pera, Andrade et al. 2004), or activin A which
promotes DE differentiation (D'Amour, Agulnick et al. 2005). Activin A treatment increased
expression of the DE markers CXCR4, CER, GSC, and DLX5 in SOX17 O/E hESCs compared
to control hESCs, while ExE genes were not expressed in BMP4-treated SOX17 O/E hESCs.
Furthermore, BMP4 treatment of SOX17 O/E hESCs actually induced DE markers, indicating
that SOX17 O/E hESCs are DE progenitor cells exclusively and incapable of ExE differentiation.
Therefore, the effect of DE cells on cardiac commitment during hESC differentiation can be
examined by generating EB cocultures containing hESCs and SOX17 O/E cells similar to the
experiments presented in Chapter 4 using SOX7 O/E hESCs.
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It would be of particular interest to contrast the effects of DE and ExE on different cardiac cell
types. In the early streak mouse embryo, a sheet of visceral endoderm is located on the anterior
embryonic surface, whereas definitive endoderm develops in the medial regions of the embryo
(Figure 5.1A) (Lewis and Tam 2006). Heart mesoderm progenitors arise in the posterior region
of the embryo and migrate towards the anterior and medial regions (Figure 5.1B) (Kinder,
Loebel et al. 2001). During gastrulation, cardiogenesis occurs in two separate progenitor cell
populations that arise from a common progenitor (Garry and Olson 2006). The first cardiac
progenitors are specified in the anterior lateral plate mesoderm to form the primary heart field
and subsequently give rise to cardiomyocytes belonging to the left ventricle and atria. The first
heart field is characterized by the unique expression of Tbx-5 and Hand1 (heart and neural crest
derivatives expressed protein-1) transcription factors (Cai, Liang et al. 2003). Pharyngeal
mesoderm cells give rise to the secondary heart field which is located medial to the primary heart
field. Cells in the secondary heart field express the transcription factors Islet-1 (Isl1) and FGF10 (Kelly, Brown et al. 2001; Cai, Liang et al. 2003) and contribute to the right ventricle and
outflow tract of the heart. Given that there is evidence for both ExE and DE promotion of
cardiogenesis and that the two heart fields arise at different times and locations in the embryo, it
may be that ExE cells play a role in specifying cardiac induction in the primary heart field while
DE cells are involved in guiding commitment of the secondary heart field.

Figure 5.1: Emerging cardiac tissue in relation to extraembryonic endoderm and definitive endoderm. (A) The
regionalization of the anterior visceral endoderm and progenitors of the definitive endoderm in the epiblast of the early
streak embryo (Lawson, Meneses et al. 1991). (B) Localization of mesodermal tissue progenitors in the epiblast/
ectoderm (light blue), the primitive streak (PS, black bar) and the mesoderm (pulled-away layer). Mesoderm tissue
composition reflects the types of progenitors that have been recruited from the epiblast through the PS in the
immediately preceding developmental stage, not those that are currently ingressing into the PS.
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INSIGHTS INTO THE DEVELOPMENT OF A BIOPROCESS FOR EFFICIENT,
LARGE SCALE PRODUCTION OF CARDIOMYOCYTES
While examining the effect of hESC aggregate size on cardiac induction provides insights into
the mechanisms of embryonic development and cell-cell interactions that guide cardiac
commitment, these studies also provide valuable information towards optimizing cardiac
production for large scale cell generation. Cell replacement therapy, drug discovery and
pharmacotoxicology are applications that require large numbers of pluripotent cell-derived cells.
We demonstrated that bioreactor cultures inoculated with micropatterned, size-controlled hESC
aggregates contain higher cell expansions (2 to 3 times) and frequency of beating aggregates (2
to 5 times) than bioreactors inoculated with non-size-controlled EBs (Niebruegge, Bauwens et al.
2009). Interestingly, the effect of controlling aggregate size exerted a greater influence on cell
expansion and frequency of beating aggregates than the effect of controlling oxygen tension in
the bioreactors which only improved yield by approximated 1.7 times under hypoxic conditions
and 1.4 times in normoxic conditions compared to uncontrolled oxygen conditions and suggests
that in aggregate-based differentiation the endogenous interactions between cells may have a
greater impact on cell fate than controlling external parameters such as oxygen concentration.
Controlling hESC aggregate size in an oxygen-controlled stirred suspension bioreactor was a
first step in developing robust scalable protocols for efficient cardiac generation. While
controlling aggregate size in the studies described in Chapter 3 did lead to a significant
improvement in cell expansion which corresponds to improved cardiomyocyte yield, cardiac
differentiation efficiency was still very low due to the serum-based induction used in these
studies. Many improvements can readily be enabled in this bioprocess. For instance, since
performing those experiments, we have established a protocol for cardiac differentiation in sizecontrolled hESC aggregates under defined conditions (serum-free) (Yang, Soonpaa et al. 2008).
Additionally, instead of micropatterning hESC aggregates, a system in which the effects of
colony size and aggregate size can not be separated, size controlled aggregates can be formed by
centrifuging a single cell suspension of hESCs in Aggrewells (Ungrin, Joshi et al. 2008), thereby
enabling us to screen the cardiogenic capacity of aggregates of varying size from one consistent
input hESC population. Using forced aggregation also allows for the production of aggregate
cocultures containing hESCs and inductive cell types (such as SOX7 O/E hESCs), which we
demonstrated in Chapter 4 could further enhance cardiac induction and maximize cardiomyocyte
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yield per input hESC in a scalable system. By combining the elements of independent control of
hESC colony and aggregate size, consistent input hESC populations, hESC aggregate cocultures
containing inductive cell types, and defined conditions that drive cardiac induction in a stirred
suspension controlled bioreactor, there is a strong potential of developing a robust system for
large scale, efficient production of cardiomyocytes.
SUMMARY AND CONCLUSIONS
The methods developed to control hESC aggregate size revealed that there is a viable range of
aggregate sizes for cardiac induction. Furthermore, the newly developed systems for controlling
aggregate size were used to elucidate a mechanism for the effect of aggregate size on cardiac
induction. Chapter 2 described the establishment of a micropatterning technique for robust
generation of uniform hESC aggregates of controlled size that were capable of cardiac
differentiation. Further it was demonstrated that differentiation trajectory in size-controlled
hESC aggregates was influenced by both MP-hESC colony and aggregate size. These findings
demonstrate the importance of controlling input hESC populations for efficient and reproducible
differentiation cultures. Specifically, reproducible, efficient (endogenous) mesoderm/cardiac
induction is dependent on the ratio of endoderm to neural precursors in the input hESC
population, which can be modulated by controlling hESC colony size, as well as on aggregate
size. In Chapter 3, it was demonstrated that large-scale differentiation of cardiomyocytes in
stirred suspension was enhanced by incorporating MP-hESC aggregates, evidenced by higher
cell expansions (2 to 3 times) and frequency of beating aggregates (2 to 5 times) compared to
stirred suspension differentiation of non-size controlled aggregates. Finally, in Chapter 3, a
direct link between hESC aggregate size, endoderm differentiation efficiency and cardiac yield
was established. Using a serum-free, forced aggregation based system for cardiac induction in
size controlled hESC aggregates, an inverse relationship between endoderm frequency and hESC
aggregate size was observed during the first 6 days of differentiation. In aggregate cocultures,
generated by forming aggregates from a mixture of SOX7 O/E ExE progenitor cells and hESCs,
it was confirmed that varying the ratio of ExE progenitors directly affects cardiac differentiation
efficiency.
Our findings suggest that there is a geometric relationship between hESC aggregate size and the
extent of endoderm development during early differentiation that subsequently impacts cardiac
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induction and differentiation efficiency, probably via the level of expression of signaling
molecules (DKK, SPARC, BMP, Wnt) originating from these ExE cells. These findings are an
important step in understanding endogenous control of cell fate through cell-cell interactions in
the hESC aggregate, and also provide insights into improving cardiac yields in large scale
cultures.
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Figure S1-1: Demonstration of cell viability following TripLE enzymatic single cell dissociation of hESCs. A)
Flow cytometry-based forward scatter and side scatter analysis of hESCs following enzymatic dissociation. B) Flow
cytometry-based analysis of 7-AAD viability staining on enzymatically dissociated hESCs.

Figure S1-2: Analysis of size controlled MP-hESC colonies reveals the influence of colony size on
differentiation trajectory. Representative qRTPCR analysis for 3 out of 7 trials for gene expression of
pluripotency marker Nanog, endoderm-associated marker CXCR4, and neural-associated marker Sox3.

Figure S1-3: Demonstration that Oct4 protein is exclusively expressed in the nucleus in the input hESC
population. Immunofluorescence images of hESC colonies stained with anti-Oct4 antibody (right), (left panel
Hoechst nuclear stain). Scale bar represents 100 microns.
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Figure S2-1: Karyotype results of H9 hESCs, Passage 52.
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Figure S2-2: EB sizes as cells/EB in spinner culture under uncontrolled (UC) and oxygen-controlled conditions
(normoxic (NO); hypoxic (HO)). Each experiment was performed with H9 (black symbols) and HES2 (white
symbols) cells (i). H9 EBs were formed by either colony scraping-off (UCEBs; ii) or by micropatterning followed
by scraping-off size-controlled EBs (MPEBs, iii). On d16 of differentiation UCEBs exhibit a necrotic morphology,
whereas patterned EBs appear compact and more uniform in size.
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Figure S3-1: Characterization of SOX7-overexpressing (SOX7 O/E) cells. (A) Levels of expression of
endoderm-associated proteins Sox7, Gata6 and SOX17 are higher in SOX7 O/E cells than in the non-Cre transfected
(no Cre) controls. Scale bar = 250 μm.
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Figure S3-2: Validation of SOX7-specific siRNA. (A) 2 days after transfecting SOX7 O/E cells with siRNA
against SOX7, SOX7 protein expression level is lower compared to SOX7 O/E cells transfected with scrambled
control siRNA. Scale bar = 250 μm. (B) Quantitative analysis of SOX7 protein knockdown in SOX7 O/E cells 2
and 4 days following transfection with siRNA against SOX7.

